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ABSTRACT
A Study of Osteocyte Apoptosis in Mechanically Loaded and Unloaded Murine Tibiae
Josiah Elihu Kessler

Previous research has provided evidence in support of apoptotic osteocytes
playing a role in the bone remodeling process. In this study, we examined the regional
and quadrantal variations of apoptotic and viable osteocytes in cyclically loaded and
unloaded samples. Left tibias of C57 Black 6 Taconic mice (C57Bl/6) were cyclically
loaded for either 2 weeks or 5 weeks, with the right tibias being used as controls. After
loading, tibias were resected, processed, and then stained using either a TUNEL stain, to
show apoptotic osteocytes, or a 2.0% methyl green solution, to reveal viable cells. Crosssectional images from each tibia were then captured and analyzed in each region (distal,
midshaft and proximal) and quadrant (cranial, lateral, caudal, and medial) by counting the
number of osteocytes, both apoptotic and viable, and subsequently calculating the
percentages and densities of those osteocytes. Individual analysis of each sample group
showed that the 5 week loaded bones, with the most statistically significant p-values, had
the most regional variations within the samples, specifically showing decreased apoptotic
and viable osteocytes in the lateral quadrants. Comparative analysis revealed a
statistically significant higher percentage and density of apoptotic osteocytes in 5 week
loaded samples compared to all other samples. This provides further quantitative
evidence in support of apoptotic osteocytes playing a role in bone remodeling.
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1. INTRODUCTION
1.1 Bone Biology
1.1.1Bone Function and Properties
Bone is a connective tissue with unique properties and functions that support the
human body. With its mineralized extracellular matrix, collagen packed outer shell and
regions of porous bone, bones, in general, are able to be rigid and strong yet maintain
some flexibility (Bilezikian, et al. 2008). These properties go hand in hand with its support,
protection, movement and metabolic functions. Bones come in various shapes and sizes
throughout the human body and provide the framework that holds the human body up,
helps it move, and protects the internal organs. For example, bones in the human skull
help protect the brain while bones that make up the rib cage protect organs like the heart
and lungs. Bones also act as lever arms that allow the human body to move and perform
basic tasks. Skeletal muscle is attached to bone via tendons, which is why bones are able
to act as a mechanical support system for muscle activity that transfers forces and enables
motion. Acting as a source of inorganic ions like calcium and phosphate, bone
participates in calcium homeostasis for the human body, releasing minerals into the
bloodstream as needed (Marieb 2005). Bone is able to perform its versatile mechanical,
protective and metabolic functions so effectively because of its structure.
1.1.2 Bone Structure
There are two main types of bone, cortical (compact) and trabecular (cancellous),
each with their own unique structure. Cortical bone, with a porosity of about 5 to 10
percent, is the denser of the two and makes up the outermost layer of bone (Figure 1).
The primary structural unit of cortical bone is the osteon. Each osteon is shaped like a
1

tube and contains concentric layers of packed collagen fibrils called lamellae. Lamellae
are also cylindrical in shape and are aligned along the long axis of the bone giving it
some strength. At the junctions of the lamellae lie lacunae or spaces in which mature
bone cells called osteocytes reside. Canaliculi are small canals that connect lacunae to
each other as well as to the central Haversian canal containing blood vessels and nerve
fibers. The processes of the osteocytes also jut into these canaliculi connecting them
together. Volkmann’s canals are a second type of canal that run perpendicular to
Haversian canals and connect these Haversion canals to each other as well as to the
membrane that lines the outer bone surface or periosteum. The endosteum is the thin,
inner membrane that lines the medullary cavity, whose walls are composed of trabecular
bone.

Figure 1. Cortical and trabecular bone structure (International Osteoporosis
Foundation, 2011)
Trabecular bone, with porosities ranging from 50 to 90 percent, is much lighter
than cortical bone and uses this structure to perform its primarily metabolic functions.
Trabecular bone is made of trabeculae, beam or strut like structures that are irregularly
arranged along lines of stress giving the bone a spongy appearance and providing some
strength and resistance. Trabeculae also contain irregularly arranged lamellae and

2

osteocytes that are connected to each other by processes residing in canaliculi. Due to its
porous nature, many of the voids in trabecular bone are filled with marrow where blood
cells are produced (Marieb 2005).
1.1.3 Bone Matrix
Bone is primarily made up of bone matrix. Bone matrix is strengthened by
calcium deposits and is made up of organic and inorganic components. Approximately
90% of the organic extracellular components are type I collagen and 10% are
proteoglycans, numerous proteins and cellular components. The large amount of collagen
seen in the organic part of the matrix is what helps give bones their elasticity and tensile
strength. The inorganic part of the matrix is made of hydroxyapatite, which accounts for
most of the weight in the matrix and thus is responsible for providing much of the
hardness and compressive strength seen in bone. When bone is being created, osteoblasts
secrete bone matrix around blood vessels. As the matrix hardens, these cells get trapped
inside and develop into osteocytes. Even though this formed bone matrix is hard and
impervious to nutrients, the canaliculi and cell to cell communication via gap junctions
allow the containing cells to receive the nutrients needed.
1.1.4 Bone Cells
Bones contain four different cell types within: osteoblasts, osteocytes, osteoclasts
and bone lining cells. Osteoblasts, osteoclasts and bone lining cells can be found on the
surfaces of bone while osteocytes are embedded within the bone matrix.
Osteoblasts, much like osteocytes and bone lining cells, develop from
osteoprogenitor cells. Osteoblasts are mononuclear, cuboidal, fully differentiated cells
whose primary job is to create bone matrix by laying down osteoid. Osteoid is produced
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at a rate of 1 micron per day. About ten to twenty percent of these osteoblasts will
become embedded in the bone matrix (Noble 2008).
Opposite of osteoblasts are osteoclasts, large, multinucleated bone cells which
resorb bone rather than lay down new bone. Osteoclasts resorb bone at a rate of about
tens of microns per day by demineralizing the bone and dissolving the present collagen
(Martin, et al. 1998). There are two important areas of its plasma membrane, the ruffled
border and the clear zone. The ruffled border is the central area in the plasma membrane
where bone resorption takes place. The clear zone is the area of the membrane that
surrounds the ruffled border and attaches the osteoclast to the bone matrix (Bilezikian, et
al. 2008).
Osteocytes, are the most common cell type, of the four, found in bone; there are
about 10 times more osteocytes than there are osteoblasts (Aarden, et al. 1994).
Osteocytes, as previously mentioned, are formed when an osteoblast gets embedded in
the bone matrix it secretes. When the osteoblast first starts getting embedded in the
matrix, that part of the matrix is still relatively weak. As other osteoblasts continue laying
down bone, the embedded osteoblast gets further secured in the matrix as the matrix
starts to calcify and the osteoblast starts changing shape and reducing in size.
Specifically, the number of organelles is reduced in the mitochondria, golgi apparatus and
endoplasmic reticulum (Bell, et al. 2008). At this point, the osteoblast becomes an
osteocyte. Osteocytes are stellate shaped and are located within lacunae and communicate
with other cells extracellularly via the canaliculi throughout the matrix and intracellularly
with other osteocytes via cytoplasmic processes utilizing gap junctions (Aarden, et al.
1994). Osteocytes, in response to loading, can produce a number of molecules that may
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be involved in osteogenesis or may undergo apoptosis, or cell death, if a lot of localized
remodeling is occurring. It has been thought that osteocytes may also be involved in
targeting osteoblasts and osteoclasts for bone remodeling due to sensing applied loads
and their related strains (Noble 2003).
A second type of cell that can result from osteoblasts are bone lining cells. Theses
long, elongated cells are inactive and neither lay down bone nor resorb it and are spread
out on newly formed surfaces of bone after remodeling has stopped. The cells will detach
when osteoclasts start resorbing bone. Bone lining cells are also thought to regulate the
influx and outflux of various ions (Bilezikian, et al. 2008).
1.2 Bone Remodeling
1.2.1 Modeling vs. Remodeling
Over the human life span there are two very important processes that occur
related to bone. The first, modeling, takes place when humans are young and involves
creating bone. This phase is all about bone formation over bone resorption as it is more
important to build and shape the mineralized tissue when there is little. For bone
modeling, bone can be resorbed in some places and placed down in others, independent
of each other (Martin, et al. 1998). The second process, remodeling, involves maintaining
and repairing these bones and occurs over the entire human life span by removing and
replacing a fraction of the bone every year; microscopic damage caused by fatigue or
loading is repaired and prevented by bone remodeling. Unlike bone modeling, bone
remodeling doesn’t usually affect the shape or size of the bone. In this phase, bone
resorption and bone formation are coupled so that all the bone taken away can be equally
replaced by new bone at the same site. This is a local event in which local factors recruit
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and regulate the necessary cells and is carried out by a groups of osteoblasts and
osteoclasts called a basic multicellular units or BMUs (Bilezikian, et al. 2008). A BMU,
shown in Figure 2, consists of about ten osteoclasts, hundreds of osteoblasts and a central
capillary to supply nutrients. BMUs go through a few stages throughout the remodeling
process, shown in Figure 3.

Figure 2. The structure of a Basic Multicellular Unit (BMU): The upper portion
shows a longitudinal section through an active BMU while the lower portion
displays a cartoon showing how the osteoclasts and osteoblasts work. The blue
osteoclasts can be seen resorbing bone, while the green osteoblasts follow laying
down unmineralized osteoid, stained blue, that slowly becomes mineralized, which
can be seen stained black. (Robling, et al. 2006).
1.2.2 Process
The first stage, activation, happens when osteoclasts are signaled to form by local
factors and start resorbing bone. This leads to the resorption stage where osteoclasts, at
the front of the BMU, start removing bone moving forward at rate of about 40
micrometers per day; osteoclasts remove bone in a cone like shape for cortical bone and
forms flat grooves if removing bone on a bone surface or in trabecular bone. The
diameter of the region dug out by osteoclasts reaches about 250 to 300 micrometers,
defining the approximate size of the secondary osteon to be formed (Robling, et al.
2006). After resorption comes the reversal stage, a ten day transition period, in which a
cement line is formed on top of the resorption space by mononuclear cells and connects
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the old bone to the new bone that will be put down on top. Next, is the formation stage
and occurs much slower than the resorption stage. Formation takes about 3 months to
complete while it took only 3 weeks for the resorption phase. During this time,
osteoblasts lay down osteoid, unmineralized matrix, upon which will be mineralized over
time. Each BMU leaves space for a Haversion canal in the bone so nutrients can be
delivered. The last stage is the resting stage, or quiescence, and involves the osteoblasts
either becoming embedded in the matrix to form osteocytes or becoming bone lining
cells, thus finishing the completion of a secondary osteon (Martin, et al. 1998).

Figure 3. The cycle of bone remodeling (Hill 1998).
1.2.3 Purpose
The structure and function of bone are recognized as entities that work hand in
hand. Bones are not just able to handle the normal loading conditions that occur every
day but are able to adjust to any additional stresses that may be placed. This thought
process was described by Julius Wolff. Wolff’s Law stated that bones will alter their
structure in response to a loading condition in order to better accommodate that load or
lack thereof (Bilezikian, et al. 2008). This describes what we see in bone remodeling. The
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loading of bone, and subsequent damage caused, as well as the disuse of bone has major
effects over the structure of the bone and is responsible for remodeling taking place.
Disuse of bone causes more bone to be removed with not as much bone being
formed during the remodeling process resulting in an overall loss of bone mass.
Mechanical loading on the other can cause more bone to be formed in response. As bone
becomes damaged, osteoclasts are signaled to remove the damaged bone and osteoblasts
are signaled to lay down the necessary new bone. A study involving the loading of rat
forelimbs showed that increasing the loading frequency increased bone formation
(Robling, et al. 2006). So, the loading conditions, including the amount of load, the
frequency it is applied and the duration of the load, all play a role in the bone remodeling
process. Overloading bone can cause microdamage within the bone, which bone
remodeling will try to repair. However, if the bone is overloaded too much, damage may
be incurred faster than the bone can repair it. If this continues, larger microcracks can
form and propagate causing stress fractures.
1.2.4 Fatigue Microdamage
Throughout our lives, our bones are constantly being subjected to multiple loads
every day. Much like any other structure, as these loads are applied over and over again,
fatigue microdamage occurs within the bone and is seen visually as microcracks. Frost
was the first one to describe microdamage in vivo. Physiologic strains and stresses form
microdamage and continued loading increases its presence. As the microdamage
increases, the material and structural properties get further weakened until the
microcracks grow larger and spread farther leading to the eventual failure of the bone in
the form of a fatigue fracture. Luckily, bone contains within it the ability to repair this
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fatigue damage in the form of bone remodeling (Robling, et al. 2006). There is evidence
that microdamage is associated with recruiting BMUs that will target specific areas where
bone remodeling is needed. In a study, by Burr and colleagues, remodeling BMUs in
dogs were shown to be likely associated with fatigue induced microcracks (Burr, et al.
1985). Another study showed that bone remodeling could be initiated by inducing
microdamage in rats, which don’t normally remodel their cortical bone (Bentolila, et al.
1998). These studies indicate a positive correlation between apoptotic osteocytes and the
recruitment of osteoclasts involved in BMU remodeling by showing that microdamage
was associated with apoptotic osteocytes and resorption cavities (Robling, et al. 2006).
For this reason, continued research has been performed regarding osteocyte apoptosis,
osteocytes as mechanosensors and osteocytes themselves and how they may be involved
in the remodeling process.
1.3 The Osteocyte
1.3.1 Mechanosensors
As previously described, osteocytes are formed when inactive osteoblasts become
embedded in the bone matrix. These osteocytes reside within spaces called lacunae that
are connected to each other by canals called canaliculi. The processes of the osteocytes
jut into these cancaliculi, creating pathways throughout the bone matrix. Gap junctions
are present at the ends of these osteocyte processes allowing osteocytes to connect with
each other. This entire network allows communication between other cells and the
transfer of nutrients to occur intracellularly as well as extracellularly (Figure 4). Because
of this large network of connectivity and the sheer amount of osteocytes spread
throughout the bone matrix, osteocytes are considered the most popular theory in terms of
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which bone cell dominates the mechanosensory activity and may be involved in
activating the bone remodeling process.

Figure 4. Osteocyte network comprised of osteocyte lacunae (A) that are connected
via canaliculi (B) to allow for communication within the network. In the middle,
resides a Haversian space (C) (Martin, et al. 1998).
Although many of the inner workings of osteocytes, in regards to their
mechanosensory capabilities and ability to support or initiate bone remodeling, remain
unknown, we do know that strain plays an important role. Bones are able to take on
various loads at different rates and can lay down new bone when the loading felt is
increased or resorb bone in the case of disuse. Strains in bone are experienced near
osteocyte lacunae. In theory, cells can feel up to seven times the deformation compared to
the strain in the tissue itself (Robling, et al. 2006). Because cellular responses within
bone control the formation and resorption of bone needed for bone remodeling, a
common theory is that the strains experienced by osteocytes are then translated into
cellular signals to make this happen, meaning that the osteocytes act as
mechanotransducers (Bonewald 2006). Various studies have already provided some
evidence to support this theory. In a study of turkey ulna, loading caused an increase in
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G6PD, a marker for cell metabolism, in osteocytes relative to local strain magnitudes
(Skerry, et al. 1989). However, osteocytes are most likely responding to strain derived
fluid flow rather than strain directly caused by mechanical loading (Bilezikian, et al.
2008). Osteocyte lacunae may also acts as pumps pushing fluid through the canaliculi
because of the strain concentrations located adjacent to them (Robling, et al. 2006).
Another study, showed that nitric oxide (NO), a free radical involved in promoting bone
formation and inhibiting bone resorption, was generated in osteocytes in response to
mechanical strain caused by flow-derived shear stress (Bakker et al. 2001). As
mechanical loads are applied to the bone, interstitial fluid can flow extracellularly
throughout the bone and osteocytes can use this fluid flow to sense strain information and
initiate the necessary cellular response (Figure 5). The means in which osteocytes
actually elicit this cellular response is also unclear. One theory suggests that osteocytes
control the bone architecture by using the strain experienced in the bone as a feedback
mechanism to maintain programmed physiological levels of strain (Lanyon 1993;
Hedgecock, et al. 2007). Another way in which osteocytes may send signals for bone
resorption or formation is through osteocyte apoptosis (Noble, et al. 1997; Power, et al.
2002; Bentolila, et al. 1998; Hedgecock, et al. 2007).

Figure 5. Mechanotransduction in bone (Klein-Nulend, et al. 1995).
11

1.4 Osteocyte Apoptosis
Apoptosis is a form of programmed cell death or suicide. Apoptosis is a
physiological form of cell death that occurs in both pathological and healthy bone. The
process of apoptosis is typically initiated by either proteins released by the mitochondria
or by activation of a cell surface death receptor in the tumor necrosis factor (TNF) family
(Hock, et al. 2001). Cells that undergo apoptosis, separate from their neighbors, shrink
and break into small pieces called apoptotic bodies (Noble 2003). In the nucleus,
chromatin starts to clump up around the nuclear membrane. As this nuclear DNA is
continually cleaved, the nucleus disappears and these clumps fill up the cytoplasm until
eventually breaking the cell into multiple, membrane-bound apoptotic bodies (Bilezikian,
et al. 2008). As this process is occurring, fluid is leaving the cell which is what causes the
cell to shrink and separate from its surroundings. These formed apoptotic bodies are
phagocytosed by specialized cells through a non-inflammatory process (Cardoso, et al.
2009). In bone, the majority of osteocytes are phagocytosed by osteoclasts near
resorption sites (Bronckers, et al. 1996). There is another type of cell death, however, and
that is necrosis. Necrosis typically affects groups of cells, and unlike apoptosis, causes
their nuclei to swell, spill their cellular contents and attract inflammatory cells. Death by
necrosis is much faster than apoptosis, is not energy dependent and not as controllable as
apoptosis (Noble 2003).
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Figure 6. The difference between necrotic and apoptotic cells (Gewies 2003).
1.4.1 Apoptosis and Bone Remodeling
Osteocytes and their connective, canalicular system provide the means to detect
any changes occurring throughout the bone and initiate bone remodeling to complete the
necessary repairs. One of the ways in which this may be made possible is through
apoptotic osteocytes and their role in bone remodeling. Apoptotic osteocytes have been
shown to lead to increased resorption of bone material, indicating that the death of
osteocytes is important in osteoclast recruitment during bone remodeling (Henriksen, et
al. 2009). In one study, Bronckers et al. showed that, in developing bone, the majority of
apoptotic osteocytes were located at sites with high levels of bone resorption (Bronckers,
et al. 1996). A study using a rabbit tibial lengthening model showed that apoptotic
osteocytes were localized in regions with osteoclast activity indicating a close
relationship between bone remodeling and apoptosis (Li, et al. 2003).
Many studies have shown there to be a U-shaped relationship between strain and
apoptosis seen in osteocytes (Jilka, et al. 2007; Noble, et al. 2003). This means that limbs
that experience physiological levels of strain show low levels of apoptotic osteocytes.
Conversely, limbs experiencing unloading or levels of strain high enough to induce
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microdamage, the two opposite ends of the spectrum, show increased levels of apoptotic
osteocytes (Jilka, et al. 2007). Thus, microdamage caused by overloading or fatigue
loading in bone also plays an important role in bone remodeling as well as how it
connects apoptotic osteocytes to bone remodeling.
A study by Verborgt et al. was performed to attempt to show a relationship
between osteocyte apoptosis, bone microdamage and bone resorption. In this study, the
ulnae of adult rats were fatigue loaded and sections were stained to be able to determine
which cells were undergoing apoptosis. Apoptotic osteocytes were found in regions
surrounding microcracks as well as in bone surrounding resorption spaces. However,
bone that was distant to the microcracks or resorption areas showed no differences when
compared to the controls. These results were consistent from 1 day after loading to 10
days after loading. Additionally, increases in empty lacunae and decreases in normal
osteocytes were observed over time. This study shows a strong correlation between
microdamage, resorption and apoptotic osteocytes (Verborgt, et al. 2000). A similar study
performed by Noble et al., attempted to study the role of apoptotic osteocytes on bone
remodeling related to loading as well. This was done by loading rats with varying levels
of strain from low to high. The rats had a loading regiment that involved loading them on
days 1-5 and days 8-12. The rats that were loaded with high enough levels of strain to
cause some damage resulted in an eight-fold increase in apoptotic osteocytes 7 days after
the overloading. Next, 14 days after the loading, new Haversian canals were formed.
Finally, 28 days after the overloading, the infilling of the resorption spaces was seen
(Noble, et al. 2003). Thus, for this study, the formation of Haversian canals never
preceded the presence of apoptotic osteocytes, supporting the hypothesis that apoptotic
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osteocytes may be the mechanism behind bone remodeling. Rats that were loaded with
low levels of strain also showed higher levels of apoptotic osteocytes relative to
physiologic levels of strain. This data also seems to support a U-shaped relationship
between apoptosis in osteocytes and strain and provides evidence that this U-shaped
relationship may be used to influence bone remodeling (Noble, et al. 2003).
A study by Hedgecock et al. correlated the regional variability in remodeling with
the regional variability in osteocyte apoptosis in rabbit tibia midshafts.
Histomorphometric analyses of the tibias showed that the remodeling parameters were
the lowest in the cranial quadrant compared to the other quadrants. TUNEL staining was
also performed in the tibias to see the regional variability of apoptosis within the samples.
The densities of apoptotic osteocytes found in the cranial quadrant were seen to be lower
than the densities in the medial quadrant. Also, the densities of osteocyte lacunae, empty
lacunae and total osteocytes were seen to be higher in the lateral quadrants compared to
the caudal quadrants. From this data, a strong statistically significant correlation was
found between the remodeling parameters and the apoptotic osteocyte density. Although
osteocyte density and lacunar density did not correlate with remodeling parameters like
the density of apoptotic osteocytes did, the authors suggested that cell viability could be
another factor added when correlating with remodeling parameters (Hedgecock, et al.
2007).
A study by Jessica Chan compared the variations associated with bone
remodeling factors and densities of apoptotic osteocytes at different regions and
quadrants within unloaded murine tibias. Bone samples were TUNEL stained to detect
apoptotic osteocytes and subsequently analyzed. The levels of bone morphogenic protein
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antagonists, noggin and gremlin, were measured and compared with the amount of
apoptotic osteocytes found for each quadrant and region within the tibia. This study
found higher densities of apoptotic osteocytes as well as higher levels of BMP
antagonists in the midshaft compared to the other regions. There was also found to be a
positive linear correlation between apoptotic osteocytes and gremlin and a negative linear
correlation between noggin and percentage of apoptotic osteocytes (Chan 2011).
1.5 Study Goals (And Previous Studies)
This study continues the work done by Jessica Chan, as previously described, by
incorporating bones that have been cyclically loaded. The objective of this study is to
calculate the density of apoptotic and viable osteocytes, filtered by region, quadrant and a
combination of both, in loaded and unloaded murine cortical bone and attempt to point
out any statistically significant differences that may be present between the loaded and
unloaded data. This study will focus on the tibias taken from the left hind limbs of
murine specimens, which were mechanically loaded for a time period of either 2 or 5
weeks. Densities of osteocytes will be compared between three regions (proximal,
midshaft and distal) and four anatomic quadrants (cranial, lateral, caudal, and medial)
present throughout the limb as well as between loaded and unloaded specimens. It is
hypothesized that osteocyte apoptosis will increase in the loaded limbs for both the 2
week and 5 week periods as a result of the additional cyclic stress placed on the bones. In
addition, regional variations in apoptotic osteocytes are expected to be enhanced as a
result of the increased loading in the limbs for both the 2 week and 5 week periods, with
the most variation expected to be seen within the 5 week loaded samples due to the
further loading seen by the samples.

16

2. MATERIALS AND METHODS
Twelve C57 Black 6 Taconic mice (C57Bl/6) were procured at 7 to 9 weeks of
age (Taconic, Oxnard, CA), and were housed in microisolation chambers located at the
California Polytechnic State University vivarium. A previous study showed that skeletal
maturity in male and female C57Bl/6 mice is reached between 3 and 6 months of age by
recording any changes in body weight, length of tibiae, bone density, bone modulus and
bone composition over a 12 month period (Somerville, et al. 2004). For this reason, the
mice used in this study were mechanically loaded once they reached 20 to 25 weeks of
age and were subsequently sacrificed at around 6 months of age, which means they
would have reached young adulthood and full skeletal maturity. The loading protocol
used in this study was approved by the animal care committee.
2.1 Mechanical Loading
Of the twelve mice procured, 4 mice were to be mechanically loaded for a period
of 2 weeks and the other 8 mice for a period of 5 weeks. For each of the mice, the left
tibia was mechanically loaded for the designated amount of time while the right tibia was
used as a control and was not loaded throughout this process; in between loading bouts,
mice experienced normal loading due to daily motion in their cages. However, due to
user error, three of the mice had to be prematurely sacrificed and were not used as data in
this study. Therefore, for this study, 3 mice were mechanically loaded for 2 weeks and 6
mice were mechanically loaded for 5 weeks using a Bose Enduratec 3220, Enduratec
signal box and WinTest PCI control system with its relevant WinTest software. In order
to use the loading equipment the mice needed to be successfully anesthetized beforehand.
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This was done by placing the mice in an isolation chamber with 4 to 5 percent isoflurane
being input at 3 liters per minute. This anesthesia equipment can be seen in Figure 7.

Figure 7. Equipment used to provide isoflurane anesthesia to subjects.
Once anesthetized, the mice were placed on the loading fixture and attached to a
nose cone channeling 2% isoflurane at 1 liter per minute (Verborgt, et al. 2000). The
loading fixture, as seen in Figure 8, is a ramp that supports most of their body weight
with a shallow groove indented into the fixture that allows the left hindlimb to be secured
in one spot so the loading plunger can apply the compressive force.
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Figure 8. Loading fixture used to support and secure the mouse during the loading
process.
With the mouse anesthetized and secured in the fixture, the Enduratec and
WinTest equipment can then be used to cyclically apply a mechanical load to the left
tibia of each mouse. This is achieved by creating a sinusoidal waveform within the
WinTest program as can be seen in Figures 9 and 10.

Figure 9. Interface in WinTest program that shows the cyclical loading procedure.
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Figure 10. Sinusoidal waveform observed while running the cyclical loading
procedure.
When the program was run, the subject’s left tibia was ramped up to the preload
of 0.2 N of compression by displacing the plunger onto the tibia at 0.05 mm per second.
A sinusoidal waveform cycles the force applied between 1.0 Newton of compression and
3.2 Newtons of compression at 4 Hz for 1200 cycles before finally ramping back down to
0.02 Newtons of compression at the end of the mechanical loading. The force values and
number of cycles were chosen to produce fatigue loading, well below the amount need to
cause any fracture, within the murine bone (Noble, et al. 2003; Verborgt, et al. 2000). A
frequency of 4 Hz was chosen to be similar to previous cyclical loading experiments and
matches normal murine stride frequency (Noble, et al. 2003; Verborgt, et al. 2000;
Mosley, et al. 1997). After the loading process was complete, each mouse was monitored
throughout the week to ensure that there were no abnormalities and that neither limb was
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being favored over the other. The mice loading protocol in its entirety can be seen in
Appendix A.
2.2 Specimen Sacrifice, Fixation and Decalcification
After 2 and 5 weeks of loading, each respective group was sacrificed. Each mouse
was successfully euthanized via cervical dislocation. After euthanization, each of the
right and left tibias, were resected and placed in sealed microcentrifuge tubes filled with a
fixative, Histochoice. Tibiae were then fixated by immersion fixation over the next 3 to 4
days and subsequently transferred into a decalcifation solution for another 3 to 4 days
prior to sample embedding. The decalcification solution was composed of 150 grams
disodium EDTA dehydrate and 15 grams NaOH. Water was added until the pH of the
solution reached 7.4 (between 700-800ml), yielding an approximate 15% EDTA solution.
2.3 Sample Processing
Following sacrifice, tissue immersion fixation, and decalcification, the tissue
samples were embedded in paraffin wax using the Shandon Excelsior ES system (Thermo
Fisher Scientific, Waltham, MA). Next, the embedded tissue blocks were secured on the
Leica RM2255 rotary microtome (Leica Microsystems, Bannockburn, IL) and seven
micron thick sections were cut from the block. Using tweezers, the sections were then
carefully floated in a warm distilled water bath (Boekel Scientific, Feasterville, PA) and
subsequently placed onto microscope slides (Thermo Fisher Scientific). Three sections
were placed on each microscope slide and were allowed to air dry for 24 hours before the
staining process. The full protocols used for the microtome and staining processes are
listed in Appendices B and C, respectively. To prepare for staining, slides were incubated
in a 40˚C oven for twenty to thirty minutes or until the paraffin wax became more
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transparent and malleable. For each staining process completed, half of the sections were
stained using the DeadEnd Colorimetric TUNEL (Terminal deoxynucleotidyl transferase
(TdT)-mediated deoxyuridine triphosphate nick-end labeling) System (Promega Corp.,
Madison, WI) to identify cellular DNA fragmentation that is characteristic of osteocyte
apoptosis. The other half of the sections were stained with a created 2.0% methyl green
solution that reveals non-apoptotic nuclei within each cross section. The methyl green
solution was created by first mixing 2.72 grams of sodium acetate into 200 ml of distilled
water, then adjusting the pH of the mixture to 4.2 using glacial acetic acid, and finally
dissolving 4.0 g methyl green (Aldrich Chemical Co., St. Louis, MO) into the resulting
mixture. Microtomed sections were split between two stains to ensure that both viable
and apoptotic osteocytes would be clearly visible throughout the counting process. To
ensure likeness between cross-sections, the sections used for the TUNEL staining were
directly adjacent to the sections used for the methyl green staining and, thus, were
approximately only seven to thirty microns apart relative to original tissue placement.
2.4 TUNEL staining and Osteocyte Apoptosis
The first step in the TUNEL staining process is to deparaffinize sections by
immersing the slides in xylene for 5 minutes. The tissue section were then rehydrated by
graded ethanol washes: 8 minutes in 100%, 3 minutes in 95%, 3 minutes in 85%, 3
minutes in 70%, and 3 minutes in 50% ethanol. The sections were then allowed to air dry
for 20 minutes. After drying, the sections were rinsed for 5 minutes in phosphate buffered
saline (PBS), refixed in Histochoice for 15 minutes and rinsed again in PBS for 10
minutes. To help permeabilize the tissue sections, 100 microliters of a 20µg/mL
proteinase K solution was used to cover the tissue sections for 10 minutes at room
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temperature. After another PBS rinse, Histochoice refixing and second PBS rinse, 100
microliters of equilibration buffer was placed on each slide to cover the sections for 10
minutes. A rTdT reaction mix was created by mixing 98 parts equilibration buffer with 1
part biotinylated nucleotide mix and 1 part rTdT enzyme. After gently blotting away the
previously equilibrated areas with tissue paper, 100 microliters of the rTdT reaction mix
was added to each slide and then covered with a plastic coverslip to evenly distribute the
reagent. The slides were then incubated for 1 hour in a humidifying chamber at 37˚C to
allow the end-labeling reaction to occur. Following incubation, coverslips were removed
and the slides were immersed in a 2x sodium-chloride sodium-citrate (SSC) wash to
terminate the reaction. Three subsequent 5 minute rinses in PBS were then performed to
remove unincorporated biotinylated nucleotides. A 0.3% hydrogen peroxide in PBS mix
was created and slides were allowed to sit in the mixture for 5 minutes to block
endogenous peroxidases. Again, the slides were rinsed three times in PBS for five
minutes each. The streptavidin HRP solution was diluted with PBS and 100 microliters of
the mixture was added to each slide and allowed to sit for 30 minutes. After three PBS
rinses, the DAB components (DAB substrate 20x buffer and DAB 20xchromagen) were
mixed with deionized water and hydrogen peroxide 20x just before use. Once mixed, 100
microliters of the DAB mixture were added to each slide and allowed to develop until
there was a light brown background. Finally, slides were rinsed several times in
deionized water, excess liquid was removed and then the slides were mounted with
Permount (Thermo Fischer Scientific).
To perform the methyl green stain, sections were deparaffinized by immersing the
slides in xylene for 5 minutes. The tissue sections were rehydrated by graded ethanol
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washes: 8 minutes in 100%, 3 minutes in 95%, 3 minutes in 85%, 3 minutes in 70%, and
3 minutes in 50% ethanol. The sections were then allowed to air dry for 20 minutes. After
drying, the sections were rinsed in deionized water for 5 minutes, allowed to sit in the 2%
methyl green solution (Aldrich Chemical Co., St. Louis, MO) for 30 seconds, and then
rinsed again in distilled water. Excess liquid was removed and then the slides were
mounted with Permount (Thermo Fischer Scientific).
2.5 Image Capture, Processing, and Analysis
To quantify osteocyte apoptosis and perform subsequent analyses, slides were
observed under full-spectrum white light using a BX41 polarizing light microscope
(Olympus Optical Co., Ltd., Center Valley, PA) at 40x magnification. Images were
captured using a Retiga EXi color camera (QImaging, Surrey, BC, Canada) and the Q
Capture Pro imaging program (QImaging). After capturing all of the necessary images,
Adobe Photoshop was used to combine all of the images taken from a specific crosssection into a single image so that there was only one image for each cross section. Three
cross sections of each stain, TUNEL and methyl green, were taken from each region,
distal, midshaft and proximal, within the right and left tibias of all 9 subjects amounting
to a grand total of 324 cross sections captured and created. A Ronchi ruler with known
lines at a size of 150 lines per mm was used to calibrate the images at 40x magnification.
Image analysis was performed using Image J (Wayne Rashband(NIH)) where images
were calibrated with the Ronchi ruler, yielding total field dimensions of 0.23 mm by 0.17
mm.
Regarding analysis, the area for each bone cross-section and the quadrants therein
contained, were calculated using the freehand selection tool within Image J. Two types of
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osteocytes were counted for each stain. For the TUNEL stain, osteocytes in lacunae with
their nuclei stained brown (Figure 11) were counted as apoptotic osteocytes. For the
methyl green stain, osteocytes in lacunae with their nuclei stained blue (Figure 12) were
counted as viable osteocytes.

Figure 11. TUNEL stained image showing stained osteocytes and empty lacunae.

Figure 12. Methyl green stained image showing stained osteocytes and empty
lacunae.
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The total number of cells in each cross-section were counted in each anatomic
quadrant (Cranial, Lateral, Caudal, Medial) and in each region (Proximal, Midshaft,
Distal) along the tibia for all subjects (Figure 13). To ensure that only cells in-plane were
counted, stained cells were only counted if they had a clearly defined lacunar wall. The
amount of apoptotic and viable osteocytes present in each subject was expressed by
calculating four different terms: the apoptotic osteocyte density (number of TUNEL
stained cells per cross-sectional area), percent apoptotic osteocytes (number of TUNEL
stained cells as a percent of the total cells counted in the cross section), viable osteocyte
density (number of methyl green stained cells per cross-sectional area) and percent viable
osteocytes (number of methyl green stained cells as a percent of the total cells counted in
the cross section).

Figure 13. An example of what cross-sectional views across 3 regions of murine
tibia look like stacked on top of each other, with samples on the left side(A) being
TUNEL stained cross-sections, and samples directly to the right (B) being methyl
green stained cross-sections (Cr=cranial, Ca=caudal, M=medial, L=lateral). To the
right of the cross-sections is an image of a tibia and fibula divided regionally to show
the corresponding regions in which each cross-section sample was taken from.
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2.6 Statistical Analysis
For this study, the statistical software Minitab 16 (Minitab) was used to analyze
and compare all data collected using general linear models (GLM, ANOVA); pairwise
comparisons were made using the Tukey method. Firstly, the four groups of tibias, 2
week loaded left tibias, 2 week control right tibias, 5 week loaded left tibias and 5 week
control right tibias, were analyzed individually to see if there were any statistically
significant differences to be seen within each group independent of the others. Next, the
groups of tibias were compared between each other. Comparisons were made between
the 2 week loaded and 2 week control samples, the 5 week loaded and 5 week control
samples, the 2 week loaded and 5 week loaded samples, and the 2 week control and 5
week control samples. For all data analyzed, differences in apoptotic osteocyte density,
percentage of apoptotic osteocytes, viable osteocyte density and percentage of viable
osteocytes were determined. These four variables were analyzed in each quadrant
(Cranial, Lateral, Caudal, Medial), region (Proximal, Midshaft, Distal), and combination
of both. Data was considered to be statistically significant if its related p-value was less
than 0.05.
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3. RESULTS
3.1 Individual statistics for left tibias loaded for 2 weeks
Below are the statistics for all of the 2 week loaded left tibias, including a
summary, analysis by quadrant, analysis by region and combinations of the latter two.
For each statistical analysis, apoptotic osteocyte density, percentage of apoptotic
osteocytes, viable osteocyte density and percentage of viable osteocytes were the
variables considered. Mean values, standard deviations and relevant p-values are shown,
with p-values less than 0.05 indicating statistically significant data.
A statistically significant lower percentage of apoptotic osteocytes can be seen in
the lateral quadrants of 2 week loaded bones compared to the cranial and medial
quadrants, when averaged across all regions. When specifically looking in the proximal
region, the lateral quadrant had significantly lower percentage of apoptotic osteocytes
than all other quadrants and a lower apoptotic osteocyte density compared to the medial
quadrant. The caudal quandrant also showed a significantly lower percentage of apoptotic
osteocytes when compared to the medial quadrant, within the proximal region. Only
analyzing samples within the midshaft region showed that the percentage of apoptotic
osteocytes within the lateral quadrant was lower than the medial quadrant. Looking
within just the distal region showed that the percentage of viable osteocytes was
significantly higher in the cranial quadrant compared to the lateral quadrant. No
statistically significant differences between regions were seen when averaged across all
quadrants. The only regional difference seen for 2 week loaded subjects, when looking
only at data from medial quadrants, was that the distal region had a significantly less
percentage of apoptotic osteocytes compared to the proximal region.

28

Table 1. Apoptotic osteocyte density, viable osteocyte density, percentage of
apoptotic osteocytes, and percentage of viable osteocytes for left tibias in all subjects
that were loaded for 2 weeks. Standard deviations in parentheses.
2 Week Loaded Mean

SUBJECT APOPTOTIC
OSTEOCYTE
DENSITY
(#/mm2)
84.274
2WL1
129.092
2WL2
162.850
2WL3
125.4(39.4)
Overall

PERCENTAGE
APOPTOTIC
OSTEOCYTES
(%)
31.6416
38.7803
41.2053
37.21(4.97)

VIABLE
OSTEOCYTE
DENSITY
(#/mm2)
166.157
268.705
232.974
222.6(52.1)

PERCENTAGE
VIABLE
OSTEOCYTES
(%)
41.8833
54.2325
48.2845
48.13(6.18)

Table 2. Quadrantal differences of apoptotic osteocyte density, viable osteocyte
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes for
left tibias in all subjects that were loaded for 2 weeks. Standard deviations in
parentheses.
2 Week Loaded Quadrant

Quadrant

Apoptotic
Osteocyte
Density
Cranial(Cr) 150.1(38.4)
88.8(40.7)
Lateral(L)
112.1(46.8)
Caudal(Cd)
146.1(34.6)
Medial(M)
.3162
Cr-L
.6711
Cr-Cd
.9993
Cr-M
.8915
L-Cd
.3662
L-M
.7374
Cd-M

%Apoptotic
Osteocytes
42.03(6.40)
26.62(5.80)
33.89(7.47)
43.42(1.92)
.0461
.3726
.9905
.4611
.0306
.2581
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Viable
Osteocyte
Density
258.3(63.3)
139.82(12.08)
211.4(52.1)
244.7(109.0)
.2252
.8340
.9945
.5984
.3087
.9303

%Viable
Osteocytes
53.54(7.96)
33.41(1.79)
45.61(6.39)
51.73(11.52)
.0514
.6129
.9912
.2896
.0770
.7704

Table 3. Mean quadrantal data gathered from the proximal region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for left tibias in all subjects that were loaded for 2
weeks. Standard deviations in parentheses.
2 Week Loaded Proximal Quadrant

Quadrant

Apoptotic
Osteocyte
Density
Cranial(Cr) 139.26(26.7)
73.68(47.6)
Lateral(L)
Caudal(Cd) 119.79(25.9)
178.15(40.5)
Medial(M)
.2001
Cr-L
.9105
Cr-Cd
.5818
Cr-M
.4526
L-Cd
.0321
L-M
.2757
Cd-M

%Apoptotic
Osteoctyes
42.49(4.23)
22.37(3.88)
35.97(4.43)
51.88(6.50)
.0043
.4105
.1630
.0368
.0003
.0166

Viable
Osteocyte
Density
248.18(118.0)
113.62(61.2)
185.28(30.6)
193.30(62.0)
.2029
.7387
.8068
.6598
.5865
.9991

%Viable
Osteocytes
54.36(14.24)
30.82(12.34)
46.44(8.26)
54.82(17.6)
.2231
.8878
1.000
.5264
.2110
.8708

Table 4. Mean quadrantal data gathered from the midshaft region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for left tibias in all subjects that were loaded for 2
weeks. Standard deviations in parentheses.
2 Week Loaded Midshaft Quadrant

Quadrant

Apoptotic
Osteocyte
Density
Cranial(Cr) 169.52(67.1)
71.92(34.1)
Lateral(L)
Caudal(Cd) 104.01(55.5)
157.92(62.4)
Medial(M)
.2238
Cr-L
.5184
Cr-Cd
.9939
Cr-M
.8946
L-Cd
.3102
L-M
.6580
Cd-M

%Apoptotic
Osteoctyes
40.59(4.18)
25.75(6.21)
33.25(8.37)
41.00(2.56)
.0534
.4498
.9997
.4319
.0472
.4072
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Viable
Osteocyte
Density
236.57(68.0)
109.51(53.8)
192.70(114.6)
256.64(168.4)
.5296
.9602
.9958
.7950
.4164
.8914

%Viable
Osteocytes
49.54(8.58)
28.75(8.46)
40.36(10.80)
46.93(14.93)
.1737
.7419
.9908
.5924
.2561
.8817

Table 5. Mean quadrantal data gathered from the distal region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for left tibias in all subjects that were loaded for 2
weeks. Standard deviations in parentheses.
2 Week Loaded Distal Quadrant

Quadrant

Apoptotic
Osteocyte
Density
Cranial(Cr) 141.53(24.6)
120.86(64.2)
Lateral(L)
Caudal(Cd) 112.62(62.2)
102.34(18.4)
Medial(M)
.9479
Cr-L
.8747
Cr-Cd
.7456
Cr-M
.9963
L-Cd
.9615
L-M
.9929
Cd-M

%Apoptotic
Osteoctyes
43.01(11.61)
31.75(12.99)
32.43(10.07)
37.39(6.00)
.5801
.6247
.9105
.9998
.9099
.9360

Viable
Osteocyte
Density
290.43(47.3)
196.34(23.2)
256.25(35.3)
284.29(112.9)
.3484
.9139
.9994
.6813
.3999
.9492

%Viable
Osteocytes
56.72(4.66)
40.67(1.78)
50.03(3.32)
53.44(8.14)
.0193
.4190
.8548
.1853
.0582
.8402

Table 6. Regional differences of apoptotic osteocyte density, viable osteocyte
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes for
left tibias in all subjects that were loaded for 2 weeks. Standard deviations in
parentheses.
2 Week Loaded Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
Osteocyte
Density
123.53(42.6)
129.12(48.0)
123.56(29.8)
.9847
1.000
.9848

%Apoptotic
Osteocytes
37.06(8.04)
36.67(2.95)
37.90(4.46)
.9959
.9812
.9603
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Viable
%Viable
Osteocyte
Osteocytes
Density
262.57(50.0)
51.66(3.72)
206.56(90.3)
44.08(9.63)
198.71(65.2)
48.65(9.80)
.6185
.5325
.5431
.8968
.9898
.7827

Table 7. Mean regional data gathered from the cranial quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for left tibias in all subjects that were loaded for 2
weeks. Standard deviations in parentheses.
2 Week Loaded Cranial Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
Osteocyte
Density
141.53(24.6)
169.52(67.1)
139.26(26.7)
.7290
.9978
.6933

%Apoptotic
Osteocytes
43.01(11.61)
40.59(4.18)
42.49(4.23)
.9192
.9961
.9489

Viable
Osteocyte
Density
290.43(47.3)
236.57(68.0)
248.18(118.)
.7210
.8142
.9841

%Viable
Osteocytes
56.72(4.66)
49.54(8.58)
54.36(14.24)
.6704
.9551
.8294

Table 8. Mean regional data gathered from the lateral quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for left tibias in all subjects that were loaded for 2
weeks. Standard deviations in parentheses.
2 Week Loaded Lateral Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
Osteocyte
Density
120.86(64.2)
71.92(34.1)
73.68(47.6)
.4977
.5203
.9990

%Apoptotic
Osteocytes
31.75(12.99)
25.75(6.21)
22.37(3.88)
.6866
.4293
.8829
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Viable
Osteocyte
Density
196.34(23.2)
109.51(53.8)
113.62(61.2)
.1548
.1765
.9942

%Viable
Osteocytes
40.67(1.78)
28.75(8.46)
30.82(12.34)
.2875
.4048
.9544

Table 9. Mean regional data gathered from the caudal quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for left tibias in all subjects that were loaded for 2
weeks. Standard deviations in parentheses.
2 Week Loaded Caudal Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
Osteocyte
Density
112.62(62.2)
104.01(55.5)
119.79(25.9)
.9763
.9835
.9232

%Apoptotic
Osteocytes
32.43(10.07)
33.25(8.37)
35.97(4.43)
.9913
.8535
.9098

Viable
%Viable
Osteocyte
Osteocytes
Density
256.25(35.3) 50.03(3.32)
192.70(114.6) 40.36(10.8)
185.28(30.6) 46.44(8.26)
.5540
.3697
.4868
.8532
.9911
.6475

Table 10. Mean regional data gathered from the medial quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for left tibias in all subjects that were loaded for 2
weeks. Standard deviations in parentheses.
2 Week Loaded Medial Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
Osteocyte
Density
102.34(18.4)
157.92(62.4)
178.15(40.5)
.3400
.1704
.8455

%Apoptotic
Osteocytes
37.39(6.00)
41.00(2.56)
51.88(6.50)
.6984
.0361
.1015
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Viable
%Viable
Osteocyte
Osteocytes
Density
284.29(112.9) 53.44(8.14)
256.64(168.4) 46.93(14.93)
193.30(62.0) 54.82(17.6)
.9590
.8434
.6540
.9921
.8078
.7812

3.2 Individual statistics for right tibias used as 2 week controls
Below are the statistics for all of the 2 week unloaded right tibias used as controls,
including a summary, analysis by quadrant, analysis by region and combinations of the
latter two. For each statistical analysis, apoptotic osteocyte density, percentage of
apoptotic osteocytes, viable osteocyte density and percentage of viable osteocytes were
the variables considered. Mean values, standard deviations and relevant p-values are
shown, with p-values less than 0.05 indicating statistically significant data.
For 2 week unloaded tibias, the percentage of apoptotic and viable osteocytes
within the lateral quadrants were significantly lower than the medial quadrants, when
averaged across all regions. The caudal quadrants showed a lower percentage of
apoptotic osteocytes compared to the medial quadrants when averaged across all regions
as well. When analyzing only within the proximal region, the lateral quadrant showed a
significantly lower percentage of apoptotic osteocytes compared to all other quadrants.
The caudal quadrant showed a lower percentage of apoptotic osteocytes as well when
compared to the cranial and medial quadrants. The apoptotic osteocyte density of the
lateral and the caudal quadrants were both significantly lower than that of the medial
quadrant. When looking at data only within the midshaft region, the percentage of viable
osteocytes was significantly lower in the lateral quadrant when compared to the cranial
and medial while the caudal quadrant was only lower than the medial. No statistically
significant differences were seen between regions when they were averaged across all
quadrants; the percentage of apoptotic osteocytes in the proximal region was lower than
that in the distal region, when solely looking at lateral quadrants.
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Table 11. Apoptotic osteocyte density, viable osteocyte density, percentage of
apoptotic osteocytes, and percentage of viable osteocytes for right tibias used as
controls in all subjects that were loaded for 2 weeks. Standard deviations in
parentheses.
2 Week Control Mean

SUBJECT APOPTOTIC
OSTEOCYTE
DENSITY
(#/mm2)
86.712
2WR1
128.724
2WR2
154.713
2WR3
123.4(34.3)
Overall

PERCENTAGE
APOPTOTIC
OSTEOCYTES
(%)
30.2028
35.1610
34.8880
33.42(2.79)

VIABLE
OSTEOCYTE
DENSITY
(#/mm2)
234.962
309.972
322.758
289.2(47.4)

PERCENTAGE
VIABLE
OSTEOCYTES
(%)
50.6915
58.2828
56.7443
55.24(4.01)

Table 12. Quadrantal differences of apoptotic osteocyte density, viable osteocyte
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes for
right tibias used as controls in all subjects that were loaded for 2 weeks. Standard
deviations in parentheses.
2 Week Control Quadrant

Quadrant

Apoptotic
Osteocyte
Density
Cranial(Cr) 128.08(34.1)
107.65(31.1)
Lateral(L)
Caudal(Cd) 112.28(33.9)
167.96(40.6)
Medial(M)
.8894
Cr-L
.9436
Cr-Cd
.5376
Cr-M
.9984
L-Cd
.2305
L-M
.2843
Cd-M

%Apoptotic
Osteocytes
36.20(2.08)
28.30(3.83)
30.21(2.91)
38.92(4.06)
.0745
.1992
.7507
.8917
.0184
.0488
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Viable
Osteocyte
Density
305.68(62.2)
242.22(34.7)
277.54(52.9)
344.32(35.6)
.4175
.8861
.7592
.8030
.1144
.3782

%Viable
Osteocytes
59.06(6.36)
46.37(1.55)
52.05(5.01)
61.03(6.19)
.0651
.3992
.9637
.5598
.0337
.2214

Table 13. Mean quadrantal data gathered from the proximal region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for right tibias used as controls in all subjects that
were loaded for 2 weeks. Standard deviations in parentheses.
2 Week Control Proximal Quadrant

Quadrant

Apoptotic
Osteocyte
Density
Cranial(Cr) 119.69(7.01)
64.08(23.4)
Lateral(L)
Caudal(Cd) 87.54(4.45)
168.77(35.7)
Medial(M)
.0552
Cr-L
.3351
Cr-Cd
.0928
Cr-M
.5757
L-Cd
.0016
L-M
.0079
Cd-M

%Apoptotic
Osteoctyes
37.96(2.02)
20.74(2.88)
29.74(1.01)
39.63(4.38)
.0004
.0314
.8879
.0200
.0002
.0119

Viable
Osteocyte
Density
314.25(20.9)
194.92(47.2)
252.90(52.5)
312.88(92.7)
.1405
.6050
1.000
.6440
.1461
.6208

%Viable
Osteocytes
60.82(0.92)
41.14(7.09)
49.47(5.94)
58.51(13.4)
.0708
.3809
.9846
.6151
.1156
.5561

Table 14. Mean quadrantal data gathered from the midshaft region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for right tibias used as controls in all subjects that
were loaded for 2 weeks. Standard deviations in parentheses.
2 Week Control Midshaft Quadrant

Quadrant

Apoptotic
Osteocyte
Density
Cranial(Cr) 133.45(46.1)
115.74(41.0)
Lateral(L)
Caudal(Cd) 115.72(46.9)
172.28(58.3)
Medial(M)
.9683
Cr-L
.9681
Cr-Cd
.7637
Cr-M
1.000
L-Cd
.5173
L-M
.5170
Cd-M

%Apoptotic
Osteoctyes
36.55(6.04)
28.43(7.06)
29.34(5.27)
37.96(6.36)
.4294
.5213
.9919
.9978
.3079
.3831
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Viable
Osteocyte
Density
291.28(113.2)
238.32(27.8)
270.63(79.6)
421.17(65.7)
.8375
.9873
.2496
.9548
.0792
.1613

%Viable
Osteocytes
58.95(7.50)
43.87(1.80)
49.77(3.04)
63.17(4.14)
.0170
.1489
.6913
.4494
.0041
.0312

Table 15. Mean quadrantal data gathered from the distal region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for right tibias used as controls in all subjects that
were loaded for 2 weeks. Standard deviations in parentheses.
2 Week Control Distal Quadrant

Quadrant

Apoptotic
Osteocyte
Density
Cranial(Cr) 131.09(54.8)
143.13(36.0)
Lateral(L)
Caudal(Cd) 133.58(57.0)
162.81(42.1)
Medial(M)
.9894
Cr-L
.9999
Cr-Cd
.8505
Cr-M
.9946
L-Cd
.9570
L-M
.8777
Cd-M

%Apoptotic
Osteoctyes
34.08(3.96)
35.72(5.44)
31.55(5.84)
39.17(3.84)
.9745
.9166
.5965
.7255
.8200
.2915

Viable
Osteocyte
Density
311.52(82.5)
293.43(67.2)
309.09(48.5)
298.90(38.3)
.9829
1.000
.9940
.9887
.9995
.9968

%Viable
Osteocytes
57.40(11.25)
54.09(9.46)
56.91(6.88)
61.43(6.88)
.9655
.9999
.9414
.9781
.7421
.9203

Table 16. Regional differences of apoptotic osteocyte density, viable osteocyte
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes for
right tibias used as controls in all subjects that were loaded for 2 weeks. Standard
deviations in parentheses.
2 Week Control Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
%Apoptotic
Osteocyte
Osteocytes
Density
138.65(49.4)
34.19(4.82)
127.87(47.9)
33.16(5.05)
103.63(11.37) 32.90(1.36)
.9430
.9495
.5674
.9229
.7518
.9968
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Viable
%Viable
Osteocyte
Osteocytes
Density
305.10(61.4) 57.41(8.62)
290.88(76.4) 54.39(2.97)
271.71(21.5) 53.92(1.24)
.9518
.7749
.7691
.7153
.9147
.9937

Table 17. Mean regional data gathered from the cranial quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for right tibias used as controls in all subjects that
were loaded for 2 weeks. Standard deviations in parentheses.
2 Week Control Cranial Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
Osteocyte
Density
131.09(54.8)
133.45(46.1)
119.69(7.01)
.9973
.9403
.9146

%Apoptotic
Osteocytes
34.08(3.96)
36.55(6.04)
37.96(2.02)
.7728
.5490
.9169

Viable
%Viable
Osteocyte
Osteocytes
Density
311.52(82.5) 57.40(11.25)
291.28(113.2) 58.95(7.50)
314.25(20.9) 60.82(0.92)
.9510
.9683
.9991
.8579
.9375
.9545

Table 18. Mean regional data gathered from the lateral quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for right tibias used as controls in all subjects that
were loaded for 2 weeks. Standard deviations in parentheses.
2 Week Control Lateral Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
Osteocyte
Density
143.13(36.0)
115.74(41.0)
64.08(23.4)
.6152
.0676
.2339

%Apoptotic
Osteocytes
35.72(5.44)
28.43(7.06)
20.74(2.88)
.2969
.0338
.2667
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Viable
Osteocyte
Density
293.43(67.2)
238.32(27.8)
194.92(47.2)
.4224
.1145
.5691

%Viable
Osteocytes
54.09(9.46)
43.87(1.80)
41.14(7.09)
.2440
.1326
.8818

Table 19. Mean regional data gathered from the caudal quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for right tibias used as controls in all subjects that
were loaded for 2 weeks. Standard deviations in parentheses.
2 Week Control Caudal Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
Osteocyte
Density
133.58(57.0)
115.72(46.9)
87.54(4.45)
.8683
.4355
.7120

%Apoptotic
Osteocytes
31.55(5.84)
29.34(5.27)
29.74(1.01)
.8293
.8806
.9938

Viable
Osteocyte
Density
309.09(48.5)
270.63(79.6)
252.90(52.5)
.7376
.5404
.9348

%Viable
Osteocytes
56.91(6.88)
49.77(3.04)
49.47(5.94)
.3233
.2986
.9976

Table 20. Mean regional data gathered from the medial quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for right tibias used as controls in all subjects that
were loaded for 2 weeks. Standard deviations in parentheses.
2 Week Control Medial Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
Osteocyte
Density
162.81(42.1)
172.28(58.3)
168.77(35.7)
.9663
.9865
.9953

%Apoptotic
Osteocytes
39.17(3.84)
37.96(6.36)
39.63(4.38)
.9532
.9929
.9127
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Viable
Osteocyte
Density
298.90(38.3)
421.17(65.7)
312.88(92.7)
.1571
.9671
.2147

%Viable
Osteocytes
61.43(6.88)
63.17(4.14)
58.51(13.4)
.9698
.9180
.8080

3.3 Individual statistics for left tibias loaded for 5 weeks
Below are the statistics for all of the 5 week loaded left tibias, including a
summary, analysis by quadrant, analysis by region and combinations of the latter two.
For each statistical analysis, apoptotic osteocyte density, percentage of apoptotic
osteocytes, viable osteocyte density and percentage of viable osteocytes were the
variables considered. Mean values, standard deviations and relevant p-values are shown,
with p-values less than 0.05 indicating statistically significant data.
For 5 week loaded data averaged across all regions, the lateral quadrants showed
significantly lower percentages of viable osteocytes when compared to all other
quadrants and significantly lower density of viable osteocytes when compared to the
cranial quadrants. When looking at samples only taken from proximal regions, the lateral
quadrants showed significantly lower percentages and densities of viable osteocytes
compared to all other quadrants. These proximal lateral quadrants also showed lower
percentages and densities of apoptotic osteocytes compared to the medial quadrants in the
same region. Only analyzing samples within the midshaft region showed that there were
significantly less percentages of viable osteocytes in the lateral quadrants compared to the
medial quadrants. Looking only at samples within the distal region showed that there
were significantly lower percentages of viable osteocytes in the lateral quadrants
compared to the cranial and medial quadrants.
When averaged across all quadrants, midshaft samples showed higher viable
osteocyte densities than the distal and proximal regions. When looking only within the
cranial quadrant, distal samples showed significantly less viable osteocyte densities than
midshaft samples. Isolating lateral quadrant samples showed significantly higher
densities of apoptotic osteocytes, percentages of apoptotic osteocytes and densities of
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viable osteocytes in the midshaft compared to in the proximal region. Regional data
solely from the caudal quadrant showed significantly higher apoptotic osteocyte densities
in the midshaft compared to the proximal regions and significantly higher densities of
viable osteocytes in the midshaft compared to both the distal and proximal regions.
Table 21. Apoptotic osteocyte density, viable osteocyte density, percentage of
apoptotic osteocytes, and percentage of viable osteocytes for left tibias in all subjects
that were loaded for 5 weeks. Standard deviations in parentheses.
5 Week Loaded Mean

SUBJECT APOPTOTIC
OSTEOCYTE
DENSITY
(#/mm2)
254.335
5WL1
237.385
5WL2
276.643
5WL3
236.360
5WL4
253.074
5WL5
168.333
5WL6
237.7(37.0)
Overall

PERCENTAGE
APOPTOTIC
OSTEOCYTES
(%)
58.0080
60.0225
61.7180
62.2560
58.8612
54.4083
59.21(2.86)
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VIABLE
OSTEOCYTE
DENSITY
(#/mm2)
288.214
321.218
338.626
296.044
374.637
339.155
326.3(52.1)

PERCENTAGE
VIABLE
OSTEOCYTES
(%)
61.8257
64.8525
64.3634
63.0723
63.5759
66.5362
64.04(1.62)

Table 22. Quadrantal differences of apoptotic osteocyte density, viable osteocyte
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes for
left tibias in all subjects that were loaded for 5 weeks. Standard deviations in
parentheses.
5 Week Loaded Quadrant

Quadrant

Apoptotic
Osteocyte
Density
Cranial(Cr) 236.27(37.8)
232.46(56.8)
Lateral(L)
Caudal(Cd) 239.50(38.3)
256.88(59.1)
Medial(M)
.9991
Cr-L
.9995
Cr-Cd
.8847
Cr-M
.9944
L-Cd
.8238
L-M
.9264
Cd-M

%Apoptotic
Osteocytes
59.90(3.83)
58.00(3.47)
58.40(3.39)
60.31(2.46)
.7587
.8635
.9964
.9967
.6336
.7555

Viable
Osteocyte
Density
348.55(35.4)
272.02(63.1)
330.77(23.34)
333.68(42.3)
.0298
.8927
.9333
.1224
.0986
.9994

%Viable
Osteocytes
67.22(1.50)
54.68(5.81)
63.75(2.72)
67.36(1.34)
.0000
.3089
.9999
.0008
.0000
.2780

Table 23. Mean quadrantal data gathered from the proximal region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for left tibias in all subjects that were loaded for 5
weeks. Standard deviations in parentheses.
5 Week Loaded Proximal Quadrant

Quadrant

Apoptotic
%Apoptotic
Osteocyte
Osteoctyes
Density
58.68(4.20)
Cranial(Cr) 222.01(28.9)
173.98(25.0)
52.43(4.98)
Lateral(L)
Caudal(Cd) 210.18(18.24) 56.97(4.00)
277.59(80.9)
63.09(4.59)
Medial(M)
.2927
.1043
Cr-L
.9691
.9089
Cr-Cd
.1845
.3423
Cr-M
.5296
.3207
L-Cd
.0042
.0026
L-M
.0811
.1135
Cd-M
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Viable
Osteocyte
Density
331.65(49.7)
198.41(64.5)
309.71(40.4)
307.77(63.3)
.0025
.9012
.8770
.0116
.0133
.999

%Viable
Osteocytes
66.40(2.15)
47.12(11.49)
64.43(5.67)
66.61(4.91)
.0006
.9600
.9999
.0018
.0005
.9472

Table 24. Mean quadrantal data gathered from the midshaft region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for left tibias in all subjects that were loaded for 5
weeks. Standard deviations in parentheses.
5 Week Loaded Midshaft Quadrant

Quadrant

Apoptotic
%Apoptotic
Osteocyte
Osteoctyes
Density
62.48(4.44)
Cranial(Cr) 255.87(71.0)
277.99(81.8)
64.35(5.50)
Lateral(L)
62.29(3.30)
Caudal(Cd) 287.88(68.9)
Medial(M) 287.24(114.6) 60.99(5.37)
.9698
.9013
Cr-L
.9162
.9999
Cr-Cd
.9206
.9477
Cr-M
.9971
.8732
L-Cd
.9976
.6172
L-M
1.000
.9644
Cd-M

Viable
Osteocyte
Density
392.50(54.7)
348.03(102.4)
382.38(54.9)
383.97(112.5)
.8037
.9968
.9981
.8970
.8842
1.000

%Viable
Osteocytes
67.41(3.49)
58.25(7.78)
63.60(5.68)
68.84(5.07)
.0527
.6626
.9717
.3901
.0211
.4080

Table 25. Mean quadrantal data gathered from the distal region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for left tibias in all subjects that were loaded for 5
weeks. Standard deviations in parentheses.
5 Week Loaded Distal Quadrant

Quadrant

Apoptotic
Osteocyte
Density
Cranial(Cr) 230.93(44.9)
245.40(77.7)
Lateral(L)
Caudal(Cd) 220.42(48.0)
205.80(43.4)
Medial(M)
.9682
Cr-L
.9873
Cr-Cd
.8594
Cr-M
.8614
L-Cd
.6093
L-M
.9673
Cd-M

%Apoptotic
Osteoctyes
58.54(6.44)
57.22(6.52)
55.96(6.80)
56.84(7.32)
.9864
.9107
.9719
.9880
.9997
.9958
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Viable
Osteocyte
Density
321.50(31.1)
269.62(68.5)
300.20(14.07)
309.30(47.7)
.2240
.8454
.9652
.6492
.4425
.9849

%Viable
Osteocytes
67.85(1.45)
58.67(2.89)
63.22(4.82)
66.62(3.26)
.0006
.1075
.9170
.1162
.0027
.3175

Table 26. Regional differences of apoptotic osteocyte density, viable osteocyte
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes for
left tibias in all subjects that were loaded for 5 weeks. Standard deviations in
parentheses.
5 Week Loaded Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
Osteocyte
Density
225.88(41.0)
272.75(68.7)
214.44(24.9)
.2459
.9122
.1263

%Apoptotic
Osteocytes
57.08(5.41)
62.78(3.77)
57.78(2.74)
.0727
.9534
.1230

Viable
%Viable
Osteocyte
Osteocytes
Density
302.42(19.36) 64.32(2.00)
377.70(52.9)
64.97(3.61)
298.83(49.0)
62.82(3.85)
.0219
.9363
.9886
.7102
.0165
.5032

Table 27. Mean regional data gathered from the cranial quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for left tibias in all subjects that were loaded for 5
weeks. Standard deviations in parentheses.
5 Week Loaded Cranial Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
Osteocyte
Density
230.93(44.9)
255.87(71.0)
222.01(28.9)
.6836
.9514
.5036

%Apoptotic
Osteocytes
58.54(6.44)
62.48(4.44)
58.68(4.20)
.4022
.9989
.4259
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Viable
Osteocyte
Density
321.50(31.1)
392.50(54.7)
331.65(49.7)
.0448
.9239
.0905

%Viable
Osteocytes
67.85(1.45)
67.41(3.49)
66.40(2.15)
.9490
.5878
.7718

Table 28. Mean regional data gathered from the lateral quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for left tibias in all subjects that were loaded for 5
weeks. Standard deviations in parentheses.
5 Week Loaded Lateral Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
Osteocyte
Density
245.40(77.7)
277.99(81.8)
173.98(25.0)
.6811
.1862
.0411

%Apoptotic
Osteocytes
57.22(6.52)
64.35(5.50)
52.43(4.98)
.1106
.3396
.0067

Viable
%Viable
Osteocyte
Osteocytes
Density
269.62(68.5) 58.67(2.89)
348.03(102.4) 58.25(7.78)
198.41(64.5) 47.12(11.49)
.2405
.9956
.3028
.0665
.0147
.0783

Table 29. Mean regional data gathered from the caudal quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for left tibias in all subjects that were loaded for 5
weeks. Standard deviations in parentheses.
5 Week Loaded Caudal Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
%Apoptotic
Osteocyte
Osteocytes
Density
220.42(48.0)
55.96(6.80)
287.88(68.9)
62.29(3.30)
210.18(18.24) 56.97(4.00)
.0781
.1004
.9322
.9341
.0400
.1829
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Viable
%Viable
Osteocyte
Osteocytes
Density
300.20(14.07) 63.22(4.82)
382.38(54.9) 63.60(5.68)
309.71(40.4) 64.43(5.67)
.0078
.9919
.9120
.9213
.0177
.9620

Table 30. Mean regional data gathered from the medial quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for left tibias in all subjects that were loaded for 5
weeks. Standard deviations in parentheses.
5 Week Loaded Medial Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
%Apoptotic
Osteocyte
Osteocytes
Density
205.80(43.4)
56.84(7.32)
287.24(114.6) 60.99(5.37)
277.59(80.9)
63.09(4.59)
.2508
.4578
.3338
.1895
.9788
.8119

Viable
%Viable
Osteocyte
Osteocytes
Density
309.30(47.7) 66.62(3.26)
383.97(112.5) 68.84(5.07)
307.77(63.3) 66.61(4.91)
.2651
.6743
.9994
1.000
.2522
.6719

3.4 Individual statistics for right tibias used as 5 week controls
Below are the statistics for all of the 5 week unloaded right tibias used as controls,
including a summary, analysis by quadrant, analysis by region and combinations of the
latter two. For each statistical analysis, apoptotic osteocyte density, percentage of
apoptotic osteocytes, viable osteocyte density and percentage of viable osteocytes were
the variables considered. Mean values, standard deviations and relevant p-values are
shown, with p-values less than 0.05 indicating statistically significant data.
No statistically significant data differences were seen between quadrants, when
averaged across all regions, or between regions, when averaged across all quadrants. The
only statistically significant difference seen showed higher viable osteocyte densities in
midshafts compared to samples in the proximal region, when analyzing within the medial
quadrant only.
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Table 31. Apoptotic osteocyte density, viable osteocyte density, percentage of
apoptotic osteocytes, and percentage of viable osteocytes for right tibias used as
controls in all subjects that were loaded for 5 weeks. Standard deviations in
parentheses.
5 Week Control Mean

SUBJECT APOPTOTIC
OSTEOCYTE
DENSITY
(#/mm2)
132.827
5WR1
148.814
5WR2
125.390
5WR3
186.986
5WR4
169.658
5WR5
126.423
5WR6
148.3(25.3)
Overall

PERCENTAGE
APOPTOTIC
OSTEOCYTES
(%)
41.1027
35.8902
32.8866
46.9419
43.1078
33.8280
38.96(5.62)

VIABLE
OSTEOCYTE
DENSITY
(#/mm2)
351.098
399.276
392.888
300.056
271.562
389.805
350.8(53.8)

PERCENTAGE
VIABLE
OSTEOCYTES
(%)
60.0203
57.1673
60.4484
68.5789
72.1905
64.6432
63.84(5.72)

Table 32. Quadrantal differences of apoptotic osteocyte density, viable osteocyte
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes for
right tibias used as controls in all subjects that were loaded for 5 weeks. Standard
deviations in parentheses.
5 Week Control Quadrant

Quadrant

Apoptotic
%Apoptotic
Osteocyte
Osteocytes
Density
41.24(4.74)
Cranial(Cr) 151.11(17.04)
154.51(36.2)
36.82(6.58)
Lateral(L)
37.35(6.70)
Caudal(Cd) 141.49(28.4)
154.90(45.1)
38.35(6.07)
Medial(M)
.9980
.5964
Cr-L
.9581
.6867
Cr-Cd
.9972
.8415
Cr-M
.9046
.9987
L-Cd
1.000
.9715
L-M
.8971
.9916
Cd-M
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Viable
Osteocyte
Density
358.88(83.2)
319.53(27.5)
368.86(59.6)
336.28(58.0)
.6770
.9916
.9151
.5054
.9626
.7872

%Viable
Osteocytes
66.72(3.11)
57.41(10.05)
64.33(7.15)
64.63(6.75)
.1466
.9384
.9575
.3673
.3316
.9999

Table 33. Mean quadrantal data gathered from the proximal region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for right tibias used as controls in all subjects that
were loaded for 5 weeks. Standard deviations in parentheses.
5 Week Control Proximal Quadrant

Quadrant

Apoptotic
%Apoptotic
Osteocyte
Osteoctyes
Density
Cranial(Cr) 150.31(18.42) 42.06(4.85)
135.35(48.8)
35.54(8.14)
Lateral(L)
38.56(6.21)
Caudal(Cd) 132.08(25.1)
165.20(61.2)
38.51(9.86)
Medial(M)
.9261
.4532
Cr-L
.8758
.8497
Cr-Cd
.9272
.8450
Cr-M
.9991
.8972
L-Cd
.6179
.9011
L-M
.5368
1.000
Cd-M

Viable
Osteocyte
Density
312.83(88.0)
265.19(37.4)
350.45(97.9)
268.59(73.3)
.7152
.8352
.7583
.2587
.9998
.2908

%Viable
Osteocytes
64.48(3.61)
54.35(11.81)
66.50(9.72)
59.62(9.94)
.2644
.9812
.8022
.1402
.7607
.5841

Table 34. Mean quadrantal data gathered from the midshaft region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for right tibias used as controls in all subjects that
were loaded for 5 weeks. Standard deviations in parentheses.
5 Week Control Midshaft Quadrant

Quadrant

Apoptotic
%Apoptotic
Osteocyte
Osteoctyes
Density
40.87(7.98)
Cranial(Cr) 164.57(27.5)
191.78(69.1)
39.62(8.77)
Lateral(L)
38.86(7.33)
Caudal(Cd) 155.41(25.9)
Medial(M) 155.11(10.82) 37.32(6.66)
.6421
.9920
Cr-L
.9779
.9687
Cr-Cd
.9758
.8557
Cr-M
.4088
.9982
L-Cd
.4018
.9546
L-M
1.000
.9855
Cd-M
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Viable
Osteocyte
Density
408.90(123.1)
365.40(99.9)
396.47(83.9)
397.45(95.8)
.8794
.9965
.9973
.9510
.9466
1.000

%Viable
Osteocytes
67.21(4.17)
58.69(11.38)
64.60(6.96)
65.21(5.78)
.2397
.9317
.9675
.5416
.4596
.9990

Table 35. Mean quadrantal data gathered from the distal region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for right tibias used as controls in all subjects that
were loaded for 5 weeks. Standard deviations in parentheses.
5 Week Control Distal Quadrant

Quadrant

Apoptotic
Osteocyte
Density
Cranial(Cr) 138.46(35.3)
136.41(26.3)
Lateral(L)
Caudal(Cd) 136.99(60.2)
144.39(79.4)
Medial(M)
.9999
Cr-L
1.000
Cr-Cd
.9975
Cr-M
1.000
L-Cd
.9941
L-M
.9953
Cd-M

%Apoptotic
Osteoctyes
40.80(10.09)
35.30(6.60)
34.62(10.86)
39.21(11.13)
.7686
.7008
.9920
.9994
.9005
.8503

Viable
Osteocyte
Density
354.90(89.4)
328.00(64.6)
359.66(81.8)
342.81(65.2)
.9267
.9995
.9925
.8873
.9864
.9802

%Viable
Osteocytes
68.47(6.75)
59.19(9.15)
61.89(9.12)
69.06(8.48)
.2565
.5414
.9994
.9443
.2113
.4710

Table 36. Regional differences of apoptotic osteocyte density, viable osteocyte
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes for
right tibias used as controls in all subjects that were loaded for 5 weeks. Standard
deviations in parentheses.
5 Week Control Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
%Apoptotic
Osteocyte
Osteocytes
Density
139.09(45.8)
37.63(8.96)
163.32(22.7)
39.67(7.46)
142.64(22.93) 39.58(5.51)
.4179
.8836
.9803
.8937
.5242
.9997
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Viable
%Viable
Osteocyte
Osteocytes
Density
350.68(71.9) 64.41(7.51)
394.35(83.1) 64.55(5.68)
307.31(69.6) 62.56(6.33)
.5838
.9993
.5881
.8774
.1447
.8601

Table 37. Mean regional data gathered from the cranial quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for right tibias used as controls in all subjects that
were loaded for 5 weeks. Standard deviations in parentheses.
5 Week Control Cranial Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
%Apoptotic
Osteocyte
Osteocytes
Density
138.46(35.3) 40.80(10.09)
164.57(27.5)
40.87(7.98)
150.31(18.42) 42.06(4.85)
.2685
.9999
.7469
.9594
.6585
.9637

Viable
%Viable
Osteocyte
Osteocytes
Density
354.90(89.4) 68.47(6.75)
408.90(123.1) 67.21(4.17)
312.83(88.0) 64.48(3.61)
.6354
.9015
.7568
.3785
.2602
.6249

Table 38. Mean regional data gathered from the lateral quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for right tibias used as controls in all subjects that
were loaded for 5 weeks. Standard deviations in parentheses.
5 Week Control Lateral Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
Osteocyte
Density
136.41(26.3)
191.78(69.1)
135.35(48.8)
.1799
.9993
.1697

%Apoptotic
Osteocytes
35.30(6.60)
39.62(8.77)
35.54(8.14)
.6194
.9985
.6507
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Viable
Osteocyte
Density
328.00(64.6)
365.40(99.9)
265.19(37.4)
.6487
.3140
.0709

%Viable
Osteocytes
59.19(9.15)
58.69(11.38)
54.35(11.81)
.9965
.7243
.7706

Table 39. Mean regional data gathered from the caudal quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for right tibias used as controls in all subjects that
were loaded for 5 weeks. Standard deviations in parentheses.
5 Week Control Caudal Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
Osteocyte
Density
136.99(60.2)
155.41(25.9)
132.08(25.1)
.7163
.9760
.5898

%Apoptotic
Osteocytes
34.62(10.86)
38.86(7.33)
38.56(6.21)
.6623
.7002
.9978

Viable
Osteocyte
Density
359.66(81.8)
396.47(83.9)
350.45(97.9)
.7539
.9821
.6460

%Viable
Osteocytes
61.89(9.12)
64.60(6.96)
66.50(9.72)
.8523
.6357
.9240

Table 40. Mean regional data gathered from the medial quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes for right tibias used as controls in all subjects that
were loaded for 5 weeks. Standard deviations in parentheses.
5 Week Control Medial Region

Region

Distal(D)
Midshaft(MS)
Proximal(P)
D-MS
D-P
MS-P

Apoptotic
%Apoptotic
Osteocyte
Osteocytes
Density
144.39(79.4) 39.21(11.13)
155.11(10.82) 37.32(6.66)
165.20(61.2)
38.51(9.86)
.9457
.9361
.8122
.9910
.9518
.9741
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Viable
Osteocyte
Density
342.81(65.2)
397.45(95.8)
268.59(73.3)
.4739
.2667
.0328

%Viable
Osteocytes
69.06(8.48)
65.21(5.78)
59.62(9.94)
.7043
.1510
.4856

3.5 Comparison Between 2 Week Loaded Left Tibias and Unloaded Right Tibia
Controls
Below are the statistics for all of the 2 week loaded left tibias compared against
all of the 2 week unloaded right tibias used as controls, including a summary, analysis by
quadrant, analysis by region and combinations of the latter two. For each statistical
analysis, apoptotic osteocyte density, percentage of apoptotic osteocytes, viable osteocyte
density and percentage of viable osteocytes were the variables considered. Mean values,
standard deviations and relevant p-values are shown, with p-values less than 0.05
indicating statistically significant data.
When comparing the 2 week loaded data against the unloaded data, only one
statistically significant difference was found; the percentage of apoptotic osteocytes in
the medial quadrant of the proximal region for the 2 week loaded bones was significantly
higher than in the 2 week unloaded bones.
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Table 41. Quadrantal differences of apoptotic osteocyte density, viable osteocyte
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes
between loaded left tibias and control right tibias in all subjects that were loaded for
2 weeks. Standard deviations in parentheses.
2 Week Loaded/2 Week Control Quadrant

Quadrant

Apoptotic
%Apoptotic Viable
%Viable
Osteocyte
Osteocytes
Osteocyte
Osteocytes
Density
Density
150.1(38.4)
42.03(6.40)
258.3(63.3)
53.54(7.96)
2WL_Cranial(Cr2WL)
88.8(40.7)
26.62(5.80) 139.82(12.08) 33.41(1.79)
2WL_Lateral(L2WL)
211.4(52.1)
45.61(6.39)
2WL_Caudal(Cd2WL) 112.1(46.8) 33.89(7.47)
146.1(34.6) 43.42(1.92) 244.7(109.0) 51.73(11.52)
2WL_Medial(M2WL)
2WR_Cranial(Cr2WR) 128.08(34.1) 36.20(2.08) 305.68(62.2) 59.06(6.36)
107.65(31.1) 28.30(3.83) 242.22(34.7) 46.37(1.55)
2WR_Lateral(L2WR)
2WR_Caudal(Cd2WR) 112.28(33.9) 30.21(2.91) 277.54(52.9) 52.05(5.01)
2WR_Medial(M2WR) 167.96(40.6) 38.92(4.06) 344.32(35.6) 61.03(6.19)
.9953
.7897
.9709
.9631
Cr2WL-Cr2wR
.9982
.9998
.4406
.2993
L2WL-L2WR
1.000
.9748
.8570
.9207
Cd2WL-Cd2WR
.9955
.9298
.4732
.6691
M2WL-M2WR
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Table 42. Mean quadrantal data gathered from the proximal region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between loaded left tibias and control
right tibias in all subjects that were loaded for 2 weeks. Standard deviations in
parentheses.
2 Week Loaded/2 Week Control Proximal Quadrant

Quadrant

2WL_Cranial(Cr2WL)
2WL_Lateral(L2WL)
2WL_Caudal(Cd2WL)
2WL_Medial(M2WL)
2WR_Cranial(Cr2WR)
2WR_Lateral(L2WR)
2WR_Caudal(Cd2WR)
2WR_Medial(M2WR)
Cr2WL-Cr2wR
L2WL-L2WR
Cd2WL-Cd2WR
M2WL-M2WR

Apoptotic
%Apoptotic
Osteocyte
Osteocytes
Density
139.26(26.7) 42.49(4.23)
73.68(47.6)
22.37(3.88)
119.79(25.9) 35.97(4.43)
178.15(40.5) 51.88(6.50)
119.69(7.01) 37.96(2.02)
64.08(23.4)
20.74(2.88)
87.54(4.45)
29.74(1.01)
168.77(35.7) 39.63(4.38)
.9906
.8489
.9999
.9995
.8788
.5610
.9999
.0285
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Viable
Osteocyte
Density
248.18(118.0)
113.62(61.2)
185.28(30.6)
193.30(62.0)
314.25(20.9)
194.92(47.2)
252.90(52.5)
312.88(92.7)
.9211
.8097
.9121
.4167

%Viable
Osteocytes
54.36(14.24)
30.82(12.34)
46.44(8.26)
54.82(17.6)
60.82(0.92)
41.14(7.09)
49.47(5.94)
58.51(13.4)
.9955
.9400
1.000
.9999

Table 43. Mean quadrantal data gathered from the midshaft region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between loaded left tibias and control
right tibias in all subjects that were loaded for 2 weeks. Standard deviations in
parentheses.
2 Week Loaded/2 Week Control Midshaft Quadrant

Quadrant

Apoptotic
Osteocyte
Density
2WL_Cranial(Cr2WL) 169.52(67.1)
71.92(34.1)
2WL_Lateral(L2WL)
2WL_Caudal(Cd2WL) 104.01(55.5)
157.92(62.4)
2WL_Medial(M2WL)
2WR_Cranial(Cr2WR) 133.45(46.1)
115.74(41.0)
2WR_Lateral(L2WR)
2WR_Caudal(Cd2WR) 115.72(46.9)
172.28(58.3)
2WR_Medial(M2WR)
.9875
Cr2WL-Cr2wR
.9638
L2WL-L2WR
1.000
Cd2WL-Cd2WR
1.000
M2WL-M2WR

%Apoptotic
Osteocytes
40.59(4.18)
25.75(6.21)
33.25(8.37)
41.00(2.56)
36.55(6.04)
28.43(7.06)
29.34(5.27)
37.96(6.36)
.9888
.9991
.9906
.9980
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Viable
Osteocyte
Density
236.57(68.0)
109.51(53.8)
192.70(114.6)
256.64(168.4)
291.28(113.2)
238.32(27.8)
270.63(79.6)
421.17(65.7)
.9958
.7168
.9682
.4507

%Viable
Osteocytes
49.54(8.58)
28.75(8.46)
40.36(10.80)
46.93(14.93)
58.95(7.50)
43.87(1.80)
49.77(3.04)
63.17(4.14)
.9603
.4041
.8598
.3244

Table 44. Mean quadrantal data gathered from the distal region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between loaded left tibias and control
right tibias in all subjects that were loaded for 2 weeks. Standard deviations in
parentheses.
2 Week Loaded/2 Week Control Distal Quadrant

Quadrant

2WL_Cranial(Cr2WL)
2WL_Lateral(L2WL)
2WL_Caudal(Cd2WL)
2WL_Medial(M2WL)
2WR_Cranial(Cr2WR)
2WR_Lateral(L2WR)
2WR_Caudal(Cd2WR)
2WR_Medial(M2WR)
Cr2WL-Cr2wR
L2WL-L2WR
Cd2WL-Cd2WR
M2WL-M2WR

Apoptotic
Osteocyte
Density
141.53(24.6)
120.86(64.2)
112.62(62.2)
102.34(18.4)
131.09(54.8)
143.13(36.0)
133.58(57.0)
162.81(42.1)
1.000
.9988
.9992
.7710

%Apoptotic
Osteocytes
43.01(11.61)
31.75(12.99)
32.43(10.07)
37.39(6.00)
34.08(3.96)
35.72(5.44)
31.55(5.84)
39.17(3.84)
.8716
.9984
1.000
1.000

Viable
%Viable
Osteocyte
Osteocytes
Density
290.43(47.3)
56.72(4.66)
196.34(23.2)
40.67(1.78)
256.25(35.3)
50.03(3.32)
284.29(112.9) 53.44(8.14)
311.52(82.5) 57.40(11.25)
293.43(67.2)
54.09(9.46)
309.09(48.5)
56.91(6.88)
298.90(38.3)
61.43(6.88)
.9999
1.000
.5799
.3569
.9635
.9285
1.000
.8615

Table 45. Regional differences of apoptotic osteocyte density, viable osteocyte
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes
between loaded left tibias and control right tibias in all subjects that were loaded for
2 weeks. Standard deviations in parentheses.
2 Week Loaded/2 Week Control Region

Quadrant

2WL_Distal(D2WL)
2WL_Midshaft(MS2WL)
2WL_Proximal(P2WL)
2WR_Distal(D2WR)
2WR_Midshaft(MS2WR)
2WR_Proximal(P2WR)
D2WL-D2wR
MS2WL-MS2WR
P2WL-P2WR

Apoptotic
%Apoptoti
Osteocyte
c
Density
Osteocytes
123.53(42.6) 37.06(8.04)
129.12(48.0) 36.67(2.95)
123.56(29.8) 37.90(4.46)
138.65(49.4) 34.19(4.82)
127.87(47.9) 33.16(5.05)
103.63(11.37) 32.90(1.36)
.9969
.9761
1.000
.9450
.9889
.8047
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Viable
Osteocyte
Density
262.57(50.0)
206.56(90.3)
198.71(65.2)
305.10(61.4)
290.88(76.4)
271.71(21.5)
.9607
.6130
.7344

%Viable
Osteocytes
51.66(3.72)
44.08(9.63)
48.65(9.80)
57.41(8.62)
54.39(2.97)
53.92(1.24)
.9038
.4870
.9301

Table 46. Mean regional data gathered from the cranial quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between loaded left tibias and control
right tibias in all subjects that were loaded for 2 weeks. Standard deviations in
parentheses.
2 Week Loaded/2 Week Control Cranial Region

Quadrant

2WL_Distal(D2WL)
2WL_Midshaft(MS2WL)
2WL_Proximal(P2WL)
2WR_Distal(D2WR)
2WR_Midshaft(MS2WR)
2WR_Proximal(P2WR)
D2WL-D2wR
MS2WL-MS2WR
P2WL-P2WR

Apoptotic
Osteocyte
Density
141.53(24.6)
169.52(67.1)
139.26(26.7)
131.09(54.8)
133.45(46.1)
119.69(7.01)
.9996
.8983
.9920

%Apoptotic
Osteocytes
43.01(11.61)
40.59(4.18)
42.49(4.23)
34.08(3.96)
36.55(6.04)
37.96(2.02)
.5112
.9612
.9385

Viable
%Viable
Osteocyte
Osteocytes
Density
290.43(47.3)
56.72(4.66)
236.57(68.0)
49.54(8.58)
248.18(118.) 54.36(14.24)
311.52(82.5) 57.40(11.25)
291.28(113.2) 58.95(7.50)
314.25(20.9)
60.82(0.92)
.9995
1.000
.9597
.7873
.9157
.9438

Table 47. Mean regional data gathered from the lateral quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between loaded left tibias and control
right tibias in all subjects that were loaded for 2 weeks. Standard deviations in
parentheses.
2 Week Loaded/2 Week Control Lateral Region

Quadrant

2WL_Distal(D2WL)
2WL_Midshaft(MS2WL)
2WL_Proximal(P2WL)
2WR_Distal(D2WR)
2WR_Midshaft(MS2WR)
2WR_Proximal(P2WR)
D2WL-D2wR
MS2WL-MS2WR
P2WL-P2WR

Apoptotic
Osteocyte
Density
120.86(64.2)
71.92(34.1)
73.68(47.6)
143.13(36.0)
115.74(41.0)
64.08(23.4)
.9859
.8050
.9997

%Apoptotic
Osteocytes
31.75(12.99)
25.75(6.21)
22.37(3.88)
35.72(5.44)
28.43(7.06)
20.74(2.88)
.9813
.9969
.9997
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Viable
Osteocyte
Density
196.34(23.2)
109.51(53.8)
113.62(61.2)
293.43(67.2)
238.32(27.8)
194.92(47.2)
.2292
.0665
.3898

%Viable
Osteocytes
40.67(1.78)
28.75(8.46)
30.82(12.34)
54.09(9.46)
43.87(1.80)
41.14(7.09)
.3523
.2447
.6082

Table 48. Mean regional data gathered from the caudal quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between loaded left tibias and control
right tibias in all subjects that were loaded for 2 weeks. Standard deviations in
parentheses.
2 Week Loaded/2 Week Control Caudal Region

Quadrant

2WL_Distal(D2WL)
2WL_Midshaft(MS2WL)
2WL_Proximal(P2WL)
2WR_Distal(D2WR)
2WR_Midshaft(MS2WR)
2WR_Proximal(P2WR)
D2WL-D2wR
MS2WL-MS2WR
P2WL-P2WR

Apoptotic
Osteocyte
Density
112.62(62.2)
104.01(55.5)
119.79(25.9)
133.58(57.0)
115.72(46.9)
87.54(4.45)
.9926
.9995
.9526

%Apoptotic
Osteocytes
32.43(10.07)
33.25(8.37)
35.97(4.43)
31.55(5.84)
29.34(5.27)
29.74(1.01)
1.000
.9731
.8407

Viable
Osteocyte
Density
256.25(35.3)
192.70(114.6)
185.28(30.6)
309.09(48.5)
270.63(79.6)
252.90(52.5)
.9192
.7104
.8096

%Viable
Osteocytes
50.03(3.32)
40.36(10.8)
46.44(8.26)
56.91(6.88)
49.77(3.04)
49.47(5.94)
.8206
.5759
.9934

Table 49. Mean regional data gathered from the medial quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between loaded left tibias and control
right tibias in all subjects that were loaded for 2 weeks. Standard deviations in
parentheses.
2 Week Loaded/2 Week Control Medial Region

Quadrant

2WL_Distal(D2WL)
2WL_Midshaft(MS2WL)
2WL_Proximal(P2WL)
2WR_Distal(D2WR)
2WR_Midshaft(MS2WR)
2WR_Proximal(P2WR)
D2WL-D2wR
MS2WL-MS2WR
P2WL-P2WR

Apoptotic
Osteocyte
Density
102.34(18.4)
157.92(62.4)
178.15(40.5)
162.81(42.1)
172.28(58.3)
168.77(35.7)
.5935
.9985
.9998

%Apoptotic Viable
Osteocytes
Osteocyte
Density
37.39(6.00) 284.29(112.9)
41.00(2.56) 256.64(168.4)
51.88(6.50)
193.30(62.0)
39.17(3.84)
298.90(38.3)
37.96(6.36)
421.17(65.7)
39.63(4.38)
312.88(92.7)
.9978
1.000
.9753
.3827
.1045
.6862
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%Viable
Osteocytes
53.44(8.14)
46.93(14.93)
54.82(17.6)
61.43(6.88)
63.17(4.14)
58.51(13.4)
.9570
.5691
.9987

3.6 Comparison Between 5 Week Loaded Left Tibias and Unloaded Right Tibia
Controls
Below are the statistics for all of the 5 week loaded left tibias compared against
all of the 5 week unloaded right tibias used as controls, including a summary, analysis by
quadrant, analysis by region and combinations of the latter two. For each statistical
analysis, apoptotic osteocyte density, percentage of apoptotic osteocytes, viable osteocyte
density and percentage of viable osteocytes were the variables considered. Mean values,
standard deviations and relevant p-values are shown, with p-values less than 0.05
indicating statistically significant data.
When comparing the 5 week loaded data against the unloaded data, the
percentage of apoptotic osteocytes, in each region, quadrant and combination of the two,
were higher in 5 week loaded bones when compared against the 5 week unloaded bones
from the same region and quadrant. No statistically significant differences in viable
osteocyte density or percentage of viable osteocytes were seen between the 5 week
loaded samples and the 5 week unloaded control samples. The density of apoptotic
osteocytes in each quadrant, averaged across all regions, were significantly higher in the
5 week loaded bones than their respective counterparts in the 5 week unloaded bones.
The medial quadrants in proximal and midshaft samples, the caudal quadrants in midshaft
samples and the lateral quadrants in distal samples showed significantly higher densities
of apoptotic osteocytes in 5 week loaded bones compared to 5 week unload bones. The
density of apoptotic osteocytes in the distal and midshaft regions, averaged across all
quadrants, were higher in 5 week loaded bones when compared against the 5 week
unloaded bones from the same region. The distal regions of cranial, lateral and caudal
quadrants showed statistically significantly higher apoptotic osteocyte densities in 5 week
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loaded samples compared to 5 week unloaded samples. The 5 week loaded midshaft
regions in the cranial, caudal and medial quadrants of bone showed statistically
significantly higher apoptotic osteocyte densities compared to 5 week unloaded samples.
Table 50. Quadrantal differences of apoptotic osteocyte density, viable osteocyte
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes
between loaded left tibias and control right tibias in all subjects that were loaded for
5 weeks. Standard deviations in parentheses.
5 Week Loaded/5 Week Control Quadrant

Quadrant

5WL_Cranial(Cr5WL)
5WL_Lateral(L5WL)
5WL_Caudal(Cd5WL)
5WL_Medial(M5WL)
5WR_Cranial(Cr5WR)
5WR_Lateral(L5WR)
5WR_Caudal(Cd5WR)
5WR_Medial(M5WR)
Cr5WL-Cr5WR
L5WL-L5WR
Cd5WL-Cd5WR
M5WL-M5WR

Apoptotic
%Apoptoti
Osteocyte
c
Density
Osteocytes
236.27(37.8) 59.90(3.83)
232.46(56.8) 58.00(3.47)
239.50(38.3) 58.40(3.39)
256.88(59.1) 60.31(2.46)
151.11(17.04) 41.24(4.74)
154.51(36.2) 36.82(6.58)
141.49(28.4) 37.35(6.70)
154.90(45.1) 38.35(6.07)
0.0221
0.0000
0.0471
0.0000
0.0051
0.0000
0.0032
0.0000

60

Viable
Osteocyte
Density
348.55(35.4)
272.02(63.1)
330.77(23.34)
333.68(42.3)
358.88(83.2)
319.53(27.5)
368.86(59.6)
336.28(58.0)
1.0000
0.7685
0.9102
1.0000

%Viable
Osteocytes
67.22(1.50)
54.68(5.81)
63.75(2.72)
67.36(1.34)
66.72(3.11)
57.41(10.05)
64.33(7.15)
64.63(6.75)
1.0000
0.9896
1.0000
0.9895

Table 51. Mean quadrantal data gathered from the proximal region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between loaded left tibias and control
right tibias in all subjects that were loaded for 5 weeks. Standard deviations in
parentheses.
5 Week Loaded/5 Week Control Proximal Quadrant

Quadrant

Apoptotic
Osteocyte
Density
222.01(28.9)
5WL_Cranial(Cr5WL)
173.98(25.0)
5WL_Lateral(L5WL)
5WL_Caudal(Cd5WL) 210.18(18.24)
277.59(80.9)
5WL_Medial(M5WL)
150.31(18.42)
5WR_Cranial(Cr5WR)
135.35(48.8)
5WR_Lateral(L5WR)
132.08(25.1)
5WR_Caudal(Cd5WR)
165.20(61.2)
5WR_Medial(M5WR)
.1170
Cr5WL-Cr5WR
.7908
L5WL-L5WR
.0662
Cd5WL-Cd5WR
.0017
M5WL-M5WR

%Apoptotic
Osteocytes
58.68(4.20)
52.43(4.98)
56.97(4.00)
63.09(4.59)
42.06(4.85)
35.54(8.14)
38.56(6.21)
38.51(9.86)
.0009
.0007
.0002
0.000
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Viable
Osteocyte
Density
331.65(49.7)
198.41(64.5)
309.71(40.4)
307.77(63.3)
312.83(88.0)
265.19(37.4)
350.45(97.9)
268.59(73.3)
.9997
.6777
.9640
.9708

%Viable
Osteocytes
66.40(2.15)
47.12(11.49)
64.43(5.67)
66.61(4.91)
64.48(3.61)
54.35(11.81)
66.50(9.72)
59.62(9.94)
.9999
.7899
.9998
.8157

Table 52. Mean quadrantal data gathered from the midshaft region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between loaded left tibias and control
right tibias in all subjects that were loaded for 5 weeks. Standard deviations in
parentheses.
5 Week Loaded/5 Week Control Midshaft Quadrant

Quadrant

5WL_Cranial(Cr5WL)
5WL_Lateral(L5WL)
5WL_Caudal(Cd5WL)
5WL_Medial(M5WL)
5WR_Cranial(Cr5WR)
5WR_Lateral(L5WR)
5WR_Caudal(Cd5WR)
5WR_Medial(M5WR)
Cr5WL-Cr5WR
L5WL-L5WR
Cd5WL-Cd5WR
M5WL-M5WR

Apoptotic
%Apoptoti
Osteocyte
c
Density
Osteocytes
255.87(71.0) 62.48(4.44)
277.99(81.8) 64.35(5.50)
287.88(68.9) 62.29(3.30)
287.24(114.6) 60.99(5.37)
164.57(27.5) 40.87(7.98)
191.78(69.1) 39.62(8.77)
155.41(25.9) 38.86(7.33)
155.11(10.82) 37.32(6.66)
.2884
0.0000
.3575
0.0000
.0283
0.0000
.0290
0.0000
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Viable
%Viable
Osteocyte
Osteocytes
Density
392.50(54.7)
67.41(3.49)
348.03(102.4) 58.25(7.78)
382.38(54.9)
63.60(5.68)
383.97(112.5) 68.84(5.07)
408.90(123.1) 67.21(4.17)
365.40(99.9) 58.69(11.38)
396.47(83.9)
64.60(6.96)
397.45(95.8)
65.21(5.78)
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
.9804

Table 53. Mean quadrantal data gathered from the distal region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between loaded left tibias and control
right tibias in all subjects that were loaded for 5 weeks. Standard deviations in
parentheses.
5 Week Loaded/5 Week Control Distal Quadrant

Quadrant

5WL_Cranial(Cr5WL)
5WL_Lateral(L5WL)
5WL_Caudal(Cd5WL)
5WL_Medial(M5WL)
5WR_Cranial(Cr5WR)
5WR_Lateral(L5WR)
5WR_Caudal(Cd5WR)
5WR_Medial(M5WR)
Cr5WL-Cr5WR
L5WL-L5WR
Cd5WL-Cd5WR
M5WL-M5WR

Apoptotic
Osteocyte
Density
230.93(44.9)
245.40(77.7)
220.42(48.0)
205.80(43.4)
138.46(35.3)
136.41(26.3)
136.99(60.2)
144.39(79.4)
.0957
.0272
.1745
.5345

%Apoptotic
Osteocytes
58.54(6.44)
57.22(6.52)
55.96(6.80)
56.84(7.32)
40.80(10.09)
35.30(6.60)
34.62(10.86)
39.21(11.13)
.0162
.0014
.0020
.0171

Viable
%Viable
Osteocyte
Osteocytes
Density
321.50(31.1)
67.85(1.45)
269.62(68.5)
58.67(2.89)
300.20(14.07) 63.22(4.82)
309.30(47.7)
66.62(3.26)
354.90(89.4)
68.47(6.75)
328.00(64.6)
59.19(9.15)
359.66(81.8)
61.89(9.12)
342.81(65.2)
69.06(8.48)
.9816
1.0000
.7369
1.0000
.7191
1.0000
.9813
.9976

Table 54. Regional differences of apoptotic osteocyte density, viable osteocyte
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes
between loaded left tibias and control right tibias in all subjects that were loaded for
5 weeks. Standard deviations in parentheses.
5 Week Loaded/5 Week Control Region

Quadrant

Apoptotic
Osteocyte
Density
225.88(41.0)
5WL_Distal(D5WL)
5WL_Midshaft(MS5WL) 272.75(68.7)
214.44(24.9)
5WL_Proximal(P5WL)
139.09(45.8)
5WR_Distal(D5WR)
5WR_Midshaft(MS5WR) 163.32(22.7)
142.64(22.93)
5WR_Proximal(P5WR)
.0115
D5WL-D5WR
.0009
MS5WL-MS5WR
.0523
P5WL-P5WR

%Apoptotic Viable
Osteocytes
Osteocyte
Density
57.08(5.41) 302.42(19.36)
62.78(3.77)
377.70(52.9)
57.78(2.74)
298.83(49.0)
37.63(8.96)
350.68(71.9)
39.67(7.46)
394.35(83.1)
39.58(5.51)
307.31(69.6)
0.0001
.7468
0.0000
.9968
0.0002
.9999
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%Viable
Osteocytes
64.32(2.00)
64.97(3.61)
62.82(3.85)
64.41(7.51)
64.55(5.68)
62.56(6.33)
1.0000
1.0000
1.0000

Table 55. Mean regional data gathered from the cranial quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between loaded left tibias and control
right tibias in all subjects that were loaded for 5 weeks. Standard deviations in
parentheses.
5 Week Loaded/5 Week Control Cranial Region

Quadrant

Apoptotic
Osteocyte
Density
230.93(44.9)
5WL_Distal(D5WL)
5WL_Midshaft(MS5WL) 255.87(71.0)
222.01(28.9)
5WL_Proximal(P5WL)
138.46(35.3)
5WR_Distal(D5WR)
5WR_Midshaft(MS5WR) 164.57(27.5)
150.31(18.42)
5WR_Proximal(P5WR)
.0065
D5WL-D5WR
.0073
MS5WL-MS5WR
.0542
P5WL-P5WR

%Apoptotic
Osteocytes
58.54(6.44)
62.48(4.44)
58.68(4.20)
40.80(10.09)
40.87(7.98)
42.06(4.85)
.0009
.0001
.0021

Viable
%Viable
Osteocyte
Osteocytes
Density
321.50(31.1) 67.85(1.45)
392.50(54.7) 67.41(3.49)
331.65(49.7) 66.40(2.15)
354.90(89.4) 68.47(6.75)
408.90(123.1) 67.21(4.17)
312.83(88.0) 64.48(3.61)
.9761
.9998
.9991
1.0000
.9983
.9581

Table 56. Mean regional data gathered from the lateral quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between loaded left tibias and control
right tibias in all subjects that were loaded for 5 weeks. Standard deviations in
parentheses.
5 Week Loaded/5 Week Control Lateral Region

Quadrant

5WL_Distal(D5WL)
5WL_Midshaft(MS5WL)
5WL_Proximal(P5WL)
5WR_Distal(D5WR)
5WR_Midshaft(MS5WR)
5WR_Proximal(P5WR)
D5WL-D5WR
MS5WL-MS5WR
P5WL-P5WR

Apoptotic
Osteocyte
Density
245.40(77.7)
277.99(81.8)
173.98(25.0)
136.41(26.3)
191.78(69.1)
135.35(48.8)
.0367
.1525
.8669

%Apoptotic
Osteocytes
57.22(6.52)
64.35(5.50)
52.43(4.98)
35.30(6.60)
39.62(8.77)
35.54(8.14)
.0001
.0000
.0024
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Viable
Osteocyte
Density
269.62(68.5)
348.03(102.4)
198.41(64.5)
328.00(64.6)
365.40(99.9)
265.19(37.4)
.7686
.9986
.6565

%Viable
Osteocytes
58.67(2.89)
58.25(7.78)
47.12(11.49)
59.19(9.15)
58.69(11.38)
54.35(11.81)
1.0000
1.0000
.7815

Table 57. Mean regional data gathered from the caudal quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between loaded left tibias and control
right tibias in all subjects that were loaded for 5 weeks. Standard deviations in
parentheses.
5 Week Loaded/5 Week Control Caudal Region

Quadrant

5WL_Distal(D5WL)
5WL_Midshaft(MS5WL)
5WL_Proximal(P5WL)
5WR_Distal(D5WR)
5WR_Midshaft(MS5WR)
5WR_Proximal(P5WR)
D5WL-D5WR
MS5WL-MS5WR
P5WL-P5WR

Apoptotic
Osteocyte
Density
220.42(48.0)
287.88(68.9)
210.18(18.24)
136.99(60.2)
155.41(25.9)
132.08(25.1)
.0354
.0003
.0565

%Apoptotic
Osteocytes
55.96(6.80)
62.29(3.30)
56.97(4.00)
34.62(10.86)
38.86(7.33)
38.56(6.21)
.0001
.0000
.0008

Viable
Osteocyte
Density
300.20(14.07)
382.38(54.9)
309.71(40.4)
359.66(81.8)
396.47(83.9)
350.45(97.9)
.6649
.9992
.9041

%Viable
Osteocytes
63.22(4.82)
63.60(5.68)
64.43(5.67)
61.89(9.12)
64.60(6.96)
66.50(9.72)
.9995
.9999
.9959

Table 58. Mean regional data gathered from the medial quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between loaded left tibias and control
right tibias in all subjects that were loaded for 5 weeks. Standard deviations in
parentheses.
5 Week Loaded/5 Week Control Medial Region

Quadrant

5WL_Distal(D5WL)
5WL_Midshaft(MS5WL)
5WL_Proximal(P5WL)
5WR_Distal(D5WR)
5WR_Midshaft(MS5WR)
5WR_Proximal(P5WR)
D5WL-D5WR
MS5WL-MS5WR
P5WL-P5WR

Apoptotic
Osteocyte
Density
205.80(43.4)
287.24(114.6)
277.59(80.9)
144.39(79.4)
155.11(10.82)
165.20(61.2)
.6896
.0393
.1100

%Apoptotic
Osteocytes
56.84(7.32)
60.99(5.37)
63.09(4.59)
39.21(11.13)
37.32(6.66)
38.51(9.86)
.0062
.0002
.0001
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Viable
Osteocyte
Density
309.30(47.7)
383.97(112.5)
307.77(63.3)
342.81(65.2)
397.45(95.8)
268.59(73.3)
.9764
.9997
.9541

%Viable
Osteocytes
66.62(3.26)
68.84(5.07)
66.61(4.91)
69.06(8.48)
65.21(5.78)
59.62(9.94)
.9873
.9309
.4670

3.7 Comparison Between 2 Week Loaded Left Tibias and 5 Week Loaded Left
Tibias
Below are the statistics for all of the 2 week loaded left tibias compared against
all of the 5 week loaded left tibias, including a summary, analysis by quadrant, analysis
by region and combinations of the latter two. For each statistical analysis, apoptotic
osteocyte density, percentage of apoptotic osteocytes, viable osteocyte density and
percentage of viable osteocytes were the variables considered. Mean values, standard
deviations and relevant p-values are shown, with p-values less than 0.05 indicating
statistically significant data.
The lateral quadrants, isolated to each region individually and averaged across all
regions; the caudal quadrants, isolated to the midshaft region and averaged across all
regions; and the medial quadrants, averaged across all regions, showed significantly
higher densities of apoptotic osteocytes in 5 week loaded bone compared to 2 week
loaded samples. The midshaft regions, when isolated to lateral quadrants, caudal
quadrants and an averaged across all quadrants, showed significantly higher densities of
apoptotic osteocytes in 5 week loaded bones compared to 2 week loaded bones as well.
The 5 week loaded quadrants, isolated to the proximal region, midshaft region and
average across all regions, and 5 week loaded regions, isolated to the cranial quadrant,
lateral quadrant, caudal quadrant and average across all quadrants, showed significantly
higher percentages of apoptotic osteocytes compared to the respective quadrants or
regions of the 2 week loaded samples. The lateral, caudal and medial quadrants, isolated
to the distal region, and the distal and midshaft regions, both isolated to medial quadrant,
also showed a significantly higher percentage of apoptotic osteocytes in the 5 week
loaded samples compared to the 2 week load samples. Lateral quadrants, when averaged
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across all regions and when isolated to the midshaft region, showed significantly higher
densities of viable osteocytes in 5 week loaded bones compared to 2 week loaded bones.
Midshaft regions, when isolated to cranial quadrants, lateral quadrants, caudal quadrants
and averaged across all quadrants, and proximal regions, isolated to the caudal quadrant,
showed significantly higher densities of viable osteocytes in 5 week loaded bones
compared to 2 week loaded bones as well. The 5 week loaded quadrants, isolated to the
distal region, midshaft region and averaged across all regions, and the 5 week loaded
regions, averaged across all quadrants, showed a significantly higher percentage of viable
osteocytes compared to the respective quadrants or regions in the 2 week loaded samples.
The midshafts, when isolated by each individual quadrant, and the proximal regions,
isolated to the caudal quadrant, also showed a significantly less percentage of viable
osteocytes in the 2 week loaded samples compared to the 5 week samples.
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Table 59. Quadrantal differences of apoptotic osteocyte density, viable osteocyte
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes
between left tibias loaded for 2 weeks and left tibias loaded for 5 weeks. Standard
deviations in parentheses.
2 Week Loaded/5 Week Loaded Quadrant

Quadrant

2WL_Cranial(Cr2WL)
2WL_Lateral(L2WL)
2WL_Caudal(Cd2WL)
2WL_Medial(M2WL)
5WL_Cranial(Cr5WL)
5WL_Lateral(L5WL)
5WL_Caudal(Cd5WL)
5WL_Medial(M5WL)
Cr2WL-Cr5WL
L2WL-L5WL
Cd2WL-Cd5WL
M2WL-M5WL

Apoptotic
%Apoptotic Viable
%Viable
Osteocyte
Osteocytes
Osteocyte
Osteocytes
Density
Density
150.1(38.4) 42.03(6.40)
258.3(63.3)
53.54(7.96)
88.8(40.7)
26.62(5.80) 139.82(12.08) 33.41(1.79)
112.1(46.8) 33.89(7.47)
211.4(52.1)
45.61(6.39)
146.1(34.6) 43.42(1.92) 244.7(109.0) 51.73(11.52)
236.27(37.8) 59.90(3.83) 348.55(35.4) 67.22(1.50)
232.46(56.8) 58.00(3.47) 272.02(63.1) 54.68(5.81)
239.50(38.3) 58.40(3.39) 330.77(23.34) 63.75(2.72)
256.88(59.1) 60.31(2.46) 333.68(42.3) 67.36(1.34)
.1950
.0001
.2539
.0126
.0036
.0000
.0230
.0001
.0125
.0000
.0518
.0005
.0416
.0001
.2685
.0031
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Table 60. Mean quadrantal data gathered from the proximal region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between left tibias loaded for 2 weeks and
left tibias loaded for 5 weeks. Standard deviations in parentheses.
2 Week Loaded/5 Week Loaded Proximal Quadrant

Quadrant

2WL_Cranial(Cr2WL)
2WL_Lateral(L2WL)
2WL_Caudal(Cd2WL)
2WL_Medial(M2WL)
5WL_Cranial(Cr5WL)
5WL_Lateral(L5WL)
5WL_Caudal(Cd5WL)
5WL_Medial(M5WL)
Cr2WL-Cr5WL
L2WL-L5WL
Cd2WL-Cd5WL
M2WL-M5WL

Apoptotic
Osteocyte
Density
139.26(26.7)
73.68(47.6)
119.79(25.9)
178.15(40.5)
222.01(28.9)
173.98(25.0)
210.18(18.24)
277.59(80.9)
.1616
.0486
.0982
.0517

%Apoptotic
Osteocytes
42.49(4.23)
22.37(3.88)
35.97(4.43)
51.88(6.50)
58.68(4.20)
52.43(4.98)
56.97(4.00)
63.09(4.59)
.0007
.0000
.0000
.0321
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Viable
Osteocyte
Density
248.18(118.0)
113.62(61.2)
185.28(30.6)
193.30(62.0)
331.65(49.7)
198.41(64.5)
309.71(40.4)
307.77(63.3)
.5521
.5331
.1211
.1882

%Viable
Osteocytes
54.36(14.24)
30.82(12.34)
46.44(8.26)
54.82(17.6)
66.40(2.15)
47.12(11.49)
64.43(5.67)
66.61(4.91)
.6081
.2472
.1550
.6323

Table 61. Mean quadrantal data gathered from the midshaft region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between left tibias loaded for 2 weeks and
left tibias loaded for 5 weeks. Standard deviations in parentheses.
2 Week Loaded/5 Week Loaded Midshaft Quadrant

Quadrant

2WL_Cranial(Cr2WL)
2WL_Lateral(L2WL)
2WL_Caudal(Cd2WL)
2WL_Medial(M2WL)
5WL_Cranial(Cr5WL)
5WL_Lateral(L5WL)
5WL_Caudal(Cd5WL)
5WL_Medial(M5WL)
Cr2WL-Cr5WL
L2WL-L5WL
Cd2WL-Cd5WL
M2WL-M5WL

Apoptotic
Osteocyte
Density
169.52(67.1)
71.92(34.1)
104.01(55.5)
157.92(62.4)
255.87(71.0)
277.99(81.8)
287.88(68.9)
287.24(114.6)
.7732
.0181
.0462
.3161

%Apoptotic
Osteocytes
40.59(4.18)
25.75(6.21)
33.25(8.37)
41.00(2.56)
62.48(4.44)
64.35(5.50)
62.29(3.30)
60.99(5.37)
.0000
.0000
.0000
.0001
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Viable
Osteocyte
Density
236.57(68.0)
109.51(53.8)
192.70(114.6)
256.64(168.4)
392.50(54.7)
348.03(102.4)
382.38(54.9)
383.97(112.5)
.2969
.0224
.1165
.5431

%Viable
Osteocytes
49.54(8.58)
28.75(8.46)
40.36(10.80)
46.93(14.93)
67.41(3.49)
58.25(7.78)
63.60(5.68)
68.84(5.07)
.0449
.0002
.0039
.0073

Table 62. Mean quadrantal data gathered from the distal region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between left tibias loaded for 2 weeks and
left tibias loaded for 5 weeks. Standard deviations in parentheses.
2 Week Loaded/5 Week Loaded Distal Quadrant

Quadrant

2WL_Cranial(Cr2WL)
2WL_Lateral(L2WL)
2WL_Caudal(Cd2WL)
2WL_Medial(M2WL)
5WL_Cranial(Cr5WL)
5WL_Lateral(L5WL)
5WL_Caudal(Cd5WL)
5WL_Medial(M5WL)
Cr2WL-Cr5WL
L2WL-L5WL
Cd2WL-Cd5WL
M2WL-M5WL

Apoptotic
Osteocyte
Density
141.53(24.6)
120.86(64.2)
112.62(62.2)
102.34(18.4)
230.93(44.9)
245.40(77.7)
220.42(48.0)
205.80(43.4)
.2893
.0451
.1178
.1481

%Apoptotic
Osteocytes
43.01(11.61)
31.75(12.99)
32.43(10.07)
37.39(6.00)
58.54(6.44)
57.22(6.52)
55.96(6.80)
56.84(7.32)
.1526
.0025
.0060
.0347

Viable
Osteocyte
Density
290.43(47.3)
196.34(23.2)
256.25(35.3)
284.29(112.9)
321.50(31.1)
269.62(68.5)
300.20(14.07)
309.30(47.7)
.9879
.4919
.9230
.9967

%Viable
Osteocytes
56.72(4.66)
40.67(1.78)
50.03(3.32)
53.44(8.14)
67.85(1.45)
58.67(2.89)
63.22(4.82)
66.62(3.26)
.0079
.0000
.0012
.0012

Table 63. Regional differences of apoptotic osteocyte density, viable osteocyte
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes
between left tibias loaded for 2 weeks and left tibias loaded for 5 weeks. Standard
deviations in parentheses.
2 Week Loaded/5 Week Loaded Region

Quadrant

2WL_Distal(D2WL)
2WL_Midshaft(MS2WL)
2WL_Proximal(P2WL)
5WL_Distal(D5WL)
5WL_Midshaft(MS5WL)
5WL_Proximal(P5WL)
D2WL-D5WL
MS2WL-MS5WL
P2WL-P5WL

Apoptotic
Osteocyte
Density
123.53(42.6)
129.12(48.0)
123.56(29.8)
225.88(41.0)
272.75(68.7)
214.44(24.9)
.0508
.0031
.1023

%Apoptotic Viable
Osteocytes
Osteocyte
Density
37.06(8.04)
262.57(50.0)
36.67(2.95)
206.56(90.3)
37.90(4.46)
198.71(65.2)
57.08(5.41) 302.42(19.36)
62.78(3.77)
377.70(52.9)
57.78(2.74)
298.83(49.0)
.0001
.8858
.0000
.0018
.0001
.1168
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%Viable
Osteocytes
51.66(3.72)
44.08(9.63)
48.65(9.80)
64.32(2.00)
64.97(3.61)
62.82(3.85)
.0251
.0002
.0101

Table 64. Mean regional data gathered from the cranial quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between left tibias loaded for 2 weeks and
left tibias loaded for 5 weeks. Standard deviations in parentheses.
2 Week Loaded/5 Week Loaded Cranial Region

Quadrant

Apoptotic
Osteocyte
Density
141.53(24.6)
2WL_Distal(D2WL)
2WL_Midshaft(MS2WL) 169.52(67.1)
139.26(26.7)
2WL_Proximal(P2WL)
230.93(44.9)
5WL_Distal(D5WL)
5WL_Midshaft(MS5WL) 255.87(71.0)
222.01(28.9)
5WL_Proximal(P5WL)
.1512
D2WL-D5WL
.1766
MS2WL-MS5WL
.2110
P2WL-P5WL

%Apoptotic
Osteocytes
43.01(11.61)
40.59(4.18)
42.49(4.23)
58.54(6.44)
62.48(4.44)
58.68(4.20)
.0142
.0004
.0100

Viable
Osteocyte
Density
290.43(47.3)
236.57(68.0)
248.18(118.)
321.50(31.1)
392.50(54.7)
331.65(49.7)
.9742
.0139
.3792

%Viable
Osteocytes
56.72(4.66)
49.54(8.58)
54.36(14.24)
67.85(1.45)
67.41(3.49)
66.40(2.15)
.1078
.0030
.0694

Table 65. Mean regional data gathered from the lateral quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between left tibias loaded for 2 weeks and
left tibias loaded for 5 weeks. Standard deviations in parentheses.
2 Week Loaded/5 Week Loaded Lateral Region

Quadrant

Apoptotic
Osteocyte
Density
120.86(64.2)
2WL_Distal(D2WL)
2WL_Midshaft(MS2WL) 71.92(34.1)
73.68(47.6)
2WL_Proximal(P2WL)
245.40(77.7)
5WL_Distal(D5WL)
5WL_Midshaft(MS5WL) 277.99(81.8)
173.98(25.0)
5WL_Proximal(P5WL)
.0928
D2WL-D5WL
.0016
MS2WL-MS5WL
.2487
P2WL-P5WL

%Apoptotic
Osteocytes
31.75(12.99)
25.75(6.21)
22.37(3.88)
57.22(6.52)
64.35(5.50)
52.43(4.98)
.0003
.0000
.0000
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Viable
Osteocyte
Density
196.34(23.2)
109.51(53.8)
113.62(61.2)
269.62(68.5)
348.03(102.4)
198.41(64.5)
.7122
.0017
.5776

%Viable
Osteocytes
40.67(1.78)
28.75(8.46)
30.82(12.34)
58.67(2.89)
58.25(7.78)
47.12(11.49)
.0583
.0007
.1033

Table 66. Mean regional data gathered from the caudal quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between left tibias loaded for 2 weeks and
left tibias loaded for 5 weeks. Standard deviations in parentheses.
2 Week Loaded/5 Week Loaded Caudal Region

Quadrant

Apoptotic
Osteocyte
Density
112.62(62.2)
2WL_Distal(D2WL)
2WL_Midshaft(MS2WL) 104.01(55.5)
119.79(25.9)
2WL_Proximal(P2WL)
220.42(48.0)
5WL_Distal(D5WL)
5WL_Midshaft(MS5WL) 287.88(68.9)
210.18(18.24)
5WL_Proximal(P5WL)
.0576
D2WL-D5WL
.0005
MS2WL-MS5WL
.1501
P2WL-P5WL

%Apoptotic
Osteocytes
32.43(10.07)
33.25(8.37)
35.97(4.43)
55.96(6.80)
62.29(3.30)
56.97(4.00)
.0002
.0000
.0008

Viable
Osteocyte
Density
256.25(35.3)
192.70(114.6)
185.28(30.6)
300.20(14.07)
382.38(54.9)
309.71(40.4)
.8239
.0004
.0255

%Viable
Osteocytes
50.03(3.32)
40.36(10.8)
46.44(8.26)
63.22(4.82)
63.60(5.68)
64.43(5.67)
.0693
.0005
.0067

Table 67. Mean regional data gathered from the medial quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between left tibias loaded for 2 weeks and
left tibias loaded for 5 weeks. Standard deviations in parentheses.
2 Week Loaded/5 Week Loaded Medial Region

Quadrant

Apoptotic
%Apoptoti
Osteocyte
c
Density
Osteocytes
102.34(18.4) 37.39(6.00)
2WL_Distal(D2WL)
2WL_Midshaft(MS2WL) 157.92(62.4) 41.00(2.56)
178.15(40.5) 51.88(6.50)
2WL_Proximal(P2WL)
205.80(43.4) 56.84(7.32)
5WL_Distal(D5WL)
5WL_Midshaft(MS5WL) 287.24(114.6) 60.99(5.37)
277.59(80.9) 63.09(4.59)
5WL_Proximal(P5WL)
.4075
.0012
D2WL-D5WL
.1929
.0009
MS2WL-MS5WL
.4495
.1018
P2WL-P5WL
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Viable
%Viable
Osteocyte
Osteocytes
Density
284.29(112.9) 53.44(8.14)
256.64(168.4) 46.93(14.93)
193.30(62.0)
54.82(17.6)
309.30(47.7)
66.62(3.26)
383.97(112.5) 68.84(5.07)
307.77(63.3)
66.61(4.91)
.9989
.2769
.4179
.0158
.5305
.3900

3.8 Comparison Between 2 Week and 5 Week Unloaded Right Tibia Controls
Below are the statistics for all of the 2 week unloaded right tibias compared
against all of the 5 week unloaded right tibias used as controls, including a summary,
analysis by quadrant, analysis by region and combinations of the latter two. For each
statistical analysis, apoptotic osteocyte density, percentage of apoptotic osteocytes, viable
osteocyte density and percentage of viable osteocytes were the variables considered.
Mean values, standard deviations and relevant p-values are shown, with p-values less
than 0.05 indicating statistically significant data. No statistically significant differences
were seen between the 2 week unloaded controls and the 5 week unloaded controls.

Table 68. Quadrantal differences of apoptotic osteocyte density, viable osteocyte
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes
between right tibias unloaded for 2 weeks and right tibias unloaded for 5 weeks
both used as controls. Standard deviations in parentheses.
2 Week Control/5 Week Control Quadrant

Quadrant

2WR_Cranial(Cr2WR)
2WR_Lateral(L2WR)
2WR_Caudal(Cd2WR)
2WR_Medial(M2WR)
5WR_Cranial(Cr5WR)
5WR_Lateral(L5WR)
5WR_Caudal(Cd5WR)
5WR_Medial(M5WR)
Cr2WR-Cr5WR
L2WR-L5WR
Cd2WR-Cd5WR
M2WR-M5WR

Apoptotic
%Apoptotic Viable
%Viable
Osteocyte
Osteocytes
Osteocyte
Osteocytes
Density
Density
128.08(34.1) 36.20(2.08) 305.68(62.2) 59.06(6.36)
107.65(31.1) 28.30(3.83) 242.22(34.7) 46.37(1.55)
112.28(33.9) 30.21(2.91) 277.54(52.9) 52.05(5.01)
167.96(40.6) 38.92(4.06) 344.32(35.6) 61.03(6.19)
151.11(17.04) 41.24(4.74) 358.88(83.2) 66.72(3.11)
154.51(36.2) 36.82(6.58) 319.53(27.5) 57.41(10.05)
141.49(28.4) 37.35(6.70) 368.86(59.6) 64.33(7.15)
154.90(45.1) 38.35(6.07) 336.28(58.0) 64.63(6.75)
.9761
.8859
.8845
.7336
.5253
.3711
.5528
.3097
.9187
.5882
.3482
.1981
.9992
1.0000
1.0000
.9939
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Table 69. Mean quadrantal data gathered from the proximal region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between right tibias unloaded for 2 weeks
and right tibias unloaded for 5 weeks both used as controls. Standard deviations in
parentheses.
2 Week Control/5 Week Control Proximal Quadrant

Quadrant

2WR_Cranial(Cr2WR)
2WR_Lateral(L2WR)
2WR_Caudal(Cd2WR)
2WR_Medial(M2WR)
5WR_Cranial(Cr5WR)
5WR_Lateral(L5WR)
5WR_Caudal(Cd5WR)
5WR_Medial(M5WR)
Cr2WR-Cr5WR
L2WR-L5WR
Cd2WR-Cd5WR
M2WR-M5WR

Apoptotic
Osteocyte
Density
119.69(7.01)
64.08(23.4)
87.54(4.45)
168.77(35.7)
150.31(18.42)
135.35(48.8)
132.08(25.1)
165.20(61.2)
.9377
.1674
.6987
1.0000

%Apoptotic
Osteocytes
37.96(2.02)
20.74(2.88)
29.74(1.01)
39.63(4.38)
42.06(4.85)
35.54(8.14)
38.56(6.21)
38.51(9.86)
.9849
.0578
.5552
1.0000
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Viable
Osteocyte
Density
314.25(20.9)
194.92(47.2)
252.90(52.5)
312.88(92.7)
312.83(88.0)
265.19(37.4)
350.45(97.9)
268.59(73.3)
1.0000
.8654
.5660
.9874

%Viable
Osteocytes
60.82(0.92)
41.14(7.09)
49.47(5.94)
58.51(13.4)
64.48(3.61)
54.35(11.81)
66.50(9.72)
59.62(9.94)
.9989
.4522
.1703
1.0000

Table 70. Mean quadrantal data gathered from the midshaft region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between right tibias unloaded for 2 weeks
and right tibias unloaded for 5 weeks both used as controls. Standard deviations in
parentheses.
2 Week Control/5 Week Control Midshaft Quadrant

Quadrant

Apoptotic
Osteocyte
Density
2WR_Cranial(Cr2WR) 133.45(46.1)
115.74(41.0)
2WR_Lateral(L2WR)
115.72(46.9)
2WR_Caudal(Cd2WR)
172.28(58.3)
2WR_Medial(M2WR)
5WR_Cranial(Cr5WR) 164.57(27.5)
191.78(69.1)
5WR_Lateral(L5WR)
155.41(25.9)
5WR_Caudal(Cd5WR)
155.11(10.82)
5WR_Medial(M5WR)
.9642
Cr2WR-Cr5WR
.2220
L2WR-L5WR
.8821
Cd2WR-Cd5WR
.9990
M2WR-M5WR

%Apoptoti
c
Osteocytes
36.55(6.04)
28.43(7.06)
29.34(5.27)
37.96(6.36)
40.87(7.98)
39.62(8.77)
38.86(7.33)
37.32(6.66)
.9894
.4034
.6009
1.0000
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Viable
Osteocyte
Density
291.28(113.2)
238.32(27.8)
270.63(79.6)
421.17(65.7)
408.90(123.1)
365.40(99.9)
396.47(83.9)
397.45(95.8)
.6615
.5735
.5851
1.0000

%Viable
Osteocytes
58.95(7.50)
43.87(1.80)
49.77(3.04)
63.17(4.14)
67.21(4.17)
58.69(11.38)
64.60(6.96)
65.21(5.78)
.6854
.0798
.0796
.9999

Table 71. Mean quadrantal data gathered from the distal region for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between right tibias unloaded for 2 weeks
and right tibias unloaded for 5 weeks both used as controls. Standard deviations in
parentheses.
2 Week Control/5 Week Control Distal Quadrant

Quadrant

2WR_Cranial(Cr2WR)
2WR_Lateral(L2WR)
2WR_Caudal(Cd2WR)
2WR_Medial(M2WR)
5WR_Cranial(Cr5WR)
5WR_Lateral(L5WR)
5WR_Caudal(Cd5WR)
5WR_Medial(M5WR)
Cr2WR-Cr5WR
L2WR-L5WR
Cd2WR-Cd5WR
M2WR-M5WR

Apoptotic
Osteocyte
Density
131.09(54.8)
143.13(36.0)
133.58(57.0)
162.81(42.1)
138.46(35.3)
136.41(26.3)
136.99(60.2)
144.39(79.4)
1.0000
1.0000
1.0000
.9996

%Apoptotic
Osteocytes
34.08(3.96)
35.72(5.44)
31.55(5.84)
39.17(3.84)
40.80(10.09)
35.30(6.60)
34.62(10.86)
39.21(11.13)
.9534
1.0000
.9996
1.0000

Viable
Osteocyte
Density
311.52(82.5)
293.43(67.2)
309.09(48.5)
298.90(38.3)
354.90(89.4)
328.00(64.6)
359.66(81.8)
342.81(65.2)
.9882
.9970
.9720
.9873

%Viable
Osteocytes
57.40(11.25)
54.09(9.46)
56.91(6.88)
61.43(6.88)
68.47(6.75)
59.19(9.15)
61.89(9.12)
69.06(8.48)
.6046
.9886
.9902
.9047

Table 72. Regional differences of apoptotic osteocyte density, viable osteocyte
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes
between right tibias unloaded for 2 weeks and right tibias unloaded for 5 weeks
both used as controls. Standard deviations in parentheses.
2 Week Control/5 Week Control Region

Quadrant

2WR_Distal(D2WR)
2WR_Midshaft(MS2WR)
2WR_Proximal(P2WR)
5WR_Distal(D5WR)
5WR_Midshaft(MS5WR)
5WR_Proximal(P5WR)
D2WR-D5WR
MS2WR-MS5WR
P2WR-P5WR

Apoptotic
Osteocyte
Density
138.65(49.4)
127.87(47.9)
103.63(11.37)
139.09(45.8)
163.32(22.7)
142.64(22.93)
1.0000
.7029
.6161

%Apoptotic
Osteocytes
34.19(4.82)
33.16(5.05)
32.90(1.36)
37.63(8.96)
39.67(7.46)
39.58(5.51)
.9760
.7366
.7174
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Viable
Osteocyte
Density
305.10(61.4)
290.88(76.4)
271.71(21.5)
350.68(71.9)
394.35(83.1)
307.31(69.6)
.9389
.3385
.9782

%Viable
Osteocytes
57.41(8.62)
54.39(2.97)
53.92(1.24)
64.41(7.51)
64.55(5.68)
62.56(6.33)
.6117
.2339
.3943

Table 73. Mean regional data gathered from the cranial quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between right tibias unloaded for 2 weeks
and right tibias unloaded for 5 weeks both used as controls. Standard deviations in
parentheses.
2 Week Control/5 Week Control Cranial Region

Quadrant

2WR_Distal(D2WR)
2WR_Midshaft(MS2WR)
2WR_Proximal(P2WR)
5WR_Distal(D5WR)
5WR_Midshaft(MS5WR)
5WR_Proximal(P5WR)
D2WR-D5WR
MS2WR-MS5WR
P2WR-P5WR

Apoptotic
Osteocyte
Density
131.09(54.8)
133.45(46.1)
119.69(7.01)
138.46(35.3)
164.57(27.5)
150.31(18.42)
.9995
.7505
.7624

%Apoptotic
Osteocytes
34.08(3.96)
36.55(6.04)
37.96(2.02)
40.80(10.09)
40.87(7.98)
42.06(4.85)
.7607
.9518
.9613

Viable
Osteocyte
Density
311.52(82.5)
291.28(113.2)
314.25(20.9)
354.90(89.4)
408.90(123.1)
312.83(88.0)
.9867
.5296
1.0000

%Viable
Osteocytes
57.40(11.25)
58.95(7.50)
60.82(0.92)
68.47(6.75)
67.21(4.17)
64.48(3.61)
.1349
.3976
.9500

Table 74. Mean regional data gathered from the lateral quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between right tibias unloaded for 2 weeks
and right tibias unloaded for 5 weeks both used as controls. Standard deviations in
parentheses.
2 Week Control/5 Week Control Lateral Region

Quadrant

2WR_Distal(D2WR)
2WR_Midshaft(MS2WR)
2WR_Proximal(P2WR)
5WR_Distal(D5WR)
5WR_Midshaft(MS5WR)
5WR_Proximal(P5WR)
D2WR-D5WR
MS2WR-MS5WR
P2WR-P5WR

Apoptotic
Osteocyte
Density
143.13(36.0)
115.74(41.0)
64.08(23.4)
136.41(26.3)
191.78(69.1)
135.35(48.8)
.9999
.2412
.3025

%Apoptotic
Osteocytes
35.72(5.44)
28.43(7.06)
20.74(2.88)
35.30(6.60)
39.62(8.77)
35.54(8.14)
1.0000
.2886
.0830
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Viable
Osteocyte
Density
293.43(67.2)
238.32(27.8)
194.92(47.2)
328.00(64.6)
365.40(99.9)
265.19(37.4)
.9751
.1164
.6711

%Viable
Osteocytes
54.09(9.46)
43.87(1.80)
41.14(7.09)
59.19(9.15)
58.69(11.38)
54.35(11.81)
.9758
.3144
.4351

Table 75. Mean regional data gathered from the caudal quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between right tibias unloaded for 2 weeks
and right tibias unloaded for 5 weeks both used as controls. Standard deviations in
parentheses.
2 Week Control/5 Week Control Caudal Region

Quadrant

Apoptotic
Osteocyte
Density
133.58(57.0)
2WR_Distal(D2WR)
2WR_Midshaft(MS2WR) 115.72(46.9)
87.54(4.45)
2WR_Proximal(P2WR)
136.99(60.2)
5WR_Distal(D5WR)
5WR_Midshaft(MS5WR) 155.41(25.9)
132.08(25.1)
5WR_Proximal(P5WR)
1.0000
D2WR-D5WR
.7471
MS2WR-MS5WR
.6499
P2WR-P5WR

%Apoptotic
Osteocytes
31.55(5.84)
29.34(5.27)
29.74(1.01)
34.62(10.86)
38.86(7.33)
38.56(6.21)
.9913
.4870
.5668

Viable
Osteocyte
Density
309.09(48.5)
270.63(79.6)
252.90(52.5)
359.66(81.8)
396.47(83.9)
350.45(97.9)
.9478
.2861
.5509

%Viable
Osteocytes
56.91(6.88)
49.77(3.04)
49.47(5.94)
61.89(9.12)
64.60(6.96)
66.50(9.72)
.9449
.1285
.0594

Table 76. Mean regional data gathered from the medial quadrant for apoptotic
osteocyte density, viable osteocyte density, percentage of apoptotic osteocytes, and
percentage of viable osteocytes compared between right tibias unloaded for 2 weeks
and right tibias unloaded for 5 weeks both used as controls. Standard deviations in
parentheses.
2 Week Control/5 Week Control Medial Region

Quadrant

2WR_Distal(D2WR)
2WR_Midshaft(MS2WR)
2WR_Proximal(P2WR)
5WR_Distal(D5WR)
5WR_Midshaft(MS5WR)
5WR_Proximal(P5WR)
D2WR-D5WR
MS2WR-MS5WR
P2WR-P5WR

Apoptotic
Osteocyte
Density
162.81(42.1)
172.28(58.3)
168.77(35.7)
144.39(79.4)
155.11(10.82)
165.20(61.2)
.9966
.9976
1.0000

%Apoptotic
Osteocytes
39.17(3.84)
37.96(6.36)
39.63(4.38)
39.21(11.13)
37.32(6.66)
38.51(9.86)
1.0000
1.0000
1.0000
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Viable
Osteocyte
Density
298.90(38.3)
421.17(65.7)
312.88(92.7)
342.81(65.2)
397.45(95.8)
268.59(73.3)
.9621
.9976
.9607

%Viable
Osteocytes
61.43(6.88)
63.17(4.14)
58.51(13.4)
69.06(8.48)
65.21(5.78)
59.62(9.94)
.7958
.9993
1.0000

4. DISCUSSION
The goal of this study was to try to find a correlation between osteocyte apoptosis
and the amount of cyclical loading applied, or lack thereof, in order to show that
apoptotic osteocytes may be an important signaling factor in the bone remodeling
process. For this study, mice were procured and used due to their easy availability,
affordability, and size, making them relatively easy to handle. Three mice were cyclically
loaded for two weeks and six mice were cyclically loaded for 5 weeks, where the right
hindlimb of each mouse was used as a control and the left hindlimb was cyclically
loaded. Hindlimbs were used as opposed to forelimbs due to their larger cross sectional
area and ability to be cyclically loaded with ease in the loading fixture utilized in this
study. After the tibias were resected, processed, and sectioned with a microtome, each
section was stained using a TUNEL assay, to detect apoptotic osteocytes, and
counterstained with methyl green to detect viable osteocytes. The density of apoptotic
osteocytes was measured by region (proximal, midshaft, and distal) and quadrant (cranial,
caudal, lateral, and medial) in loaded and unloaded murine cortical bone. The percent of
apoptotic osteocytes, density of viable osteocytes and percent of viable osteocytes were
also similarly quantified. Statistical analyses were performed on all loaded and unloaded
samples independently of each other as well as compared against each other in order to
find any statistically significant data. Samples were analyzed by comparing quadrants,
averaged across all regions and then isolated to each individual region as well, and then
by comparing regions, averaged across all quadrants as well as isolated to each individual
quadrant. In this study, it was hypothesized that higher amounts of apoptotic osteocytes
would be seen in bones that were cyclically loaded when compared against unloaded
bones, with the highest amount seen in the 5 week loaded bones. It was also hypothesized
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that more pronounced regional variation would be seen in the 5 week loaded samples
compared to the 2 week loaded samples as a result of the additional loading that they
experienced.
Looking, individually, at each type of bone analyzed in this study, 2 week loaded,
2 week unloaded, 5 week loaded and 5 week unloaded, a number of trends and
statistically significant information could be seen. As a general trend, 2 week loaded
bones had densities and percentages of both viable and apoptotic osteocytes that were
much lower in the lateral quadrant and slightly lower in the caudal quadrant, when both
were compared to the other two quadrants. This trend was generally strongest in the
proximal region for apoptotic osteocytes and strongest in the distal region for viable
osteocytes. Similarly, for 2 week unloaded bones, viable and apoptotic osteocytes were
much lower in the lateral quadrant and slightly lower in the caudal quadrant, when
compared to the other two quadrants, with this trend being the strongest in the proximal
region for apoptotic osteocytes and strongest in the midshaft for viable osteocytes.
Generally, 5 week loaded bone showed lower viable osteocytes in the lateral quadrant,
compared to the other quadrants, with this trend being strongest in the proximal region.
Another general trend for 5 week loaded bone was that higher apoptotic and viable
osteocytes were seen in the midshafts compared to the other regions, when averaged
across all quadrants. No trends and only one statistically significant difference was seen
within the 5 week unloaded bone data; when looking only within the medial quadrant, a
higher density of viable osteocytes were seen in the midshaft compared to the proximal
region. Overall, 5 week loaded samples showed the most variation within themselves
with 24 significant p-values found in the analysis.
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Comparing the results from this study to the data presented in a similar previous
study, by Jessica Chan, yields some similarities (Chan 2011). No cyclical loading,
however, was performed in the latter study and, thus, only data from individual control
samples in this study can be compared to the data presented in her study. In both studies,
there weren't a lot of statistically significant findings, when looking solely at differences
within unloaded bone samples. However, when analyzing samples by quadrant, the
current study showed some general trends, with some statistically significant p-values, of
lower apoptotic and viable osteocyte values in the lateral and caudal quadrants when
compared to the other quadrants. Jessica's research showed a similar trend for the
apoptotic and viable osteocyte densities, although no statistically significant p-values
were found to support this trend in her study. Only a few statistically significant
differences were found in Jessica's study; midshafts were shown to have higher viable
and apoptotic osteocytes when compared to the other regions. In the current study,
although not seen in 2 week samples, this trend was similarly observed within the 5 week
loaded and unloaded samples, with statistically significant p-values only seen in the 5
week loaded samples. Differences observed between the samples used in this study and
the samples from Jessica's study may be due to the fact that a lower quantity of mice that
were younger in age, and possibly skeletal maturity, were used in the study performed by
her. Overall, given that the samples analyzed in Jessica's study only yielded some
statistically significant p-values when looking at the midshafts, and nowhere else, the
most prevalent trend between samples used in both studies is the general lack of
statistically significant findings seen for unloaded bone samples. This should then
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provide some evidence that the control samples in this study and the samples used in
Jessica's study are relatively similar (Chan 2011).
In order to shed more light on the role of apoptotic osteocytes in the remodeling
process, statistical analyses comparing each type of sample, loaded and unloaded, to one
another is necessary. The first comparison analyzed in this study was 2 week loaded
samples against 2 week unloaded control samples. When comparing 2 week loaded bones
samples against 2 week unloaded control samples, only one statistically significant
difference was found; the percentage of apoptotic osteocytes in 2 week loaded samples
was shown to be higher than the 2 week unloaded bones when analyzed within the medial
quadrant of the proximal region. Overall, the 2 week loaded samples showed little
statistically significant differences to the unloaded samples. However, 2 week loaded
bones showed a trend of slightly more apoptotic osteocytes and less viable osteocytes
than 2 week control samples, even though there weren't any statistically significant pvalues to support this trend. This could be because 2 weeks is only enough time to reach
the start of the remodeling process. A study by Noble et al. showed that load induced
DNA damage is followed by cellular apoptosis process within 2 weeks of initial damage
stimulus (Noble, et al. 2003). In the study, at 14 days after loading, less cells with DNA
fragmentation and less viable cells were observed as well as the first signs of Haversion
remodeling (Noble, et al. 2003). This observation from Noble's study could explain the
general trend of slightly more apoptotic osteocytes, less viable osteocytes and overall
lack of statistically significant differences seen in this study's samples loaded for 2
weeks, when compared to the controls. 5 week unloaded and 2 week unloaded samples
were also compared against one another. As expected, the 2 week unloaded and 5 week
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unloaded samples showed no statistically significant differences when compared against
each other. Given that the samples cyclically loaded for the most amount of time were
expected to show the most differences when compared against unloaded samples, 5 week
loaded samples were compared against both 5 week unloaded and 2 week loaded
samples.
As previously mentioned before, no significant differences were found between 2
week loaded samples and 2 week unloaded samples nor between 2 week unloaded
samples and 5 week unloaded samples. It makes sense, then, that comparing 5 week
loaded samples against both 5 week unloaded samples and 2 week loaded samples
yielded many similarities. Except for two statistically insignificant p-values when
compared with 2 week loaded samples, all locations within 5 week loaded samples
showed significantly higher percentages of apoptotic osteocytes than those of both the 5
week unloaded samples and the 2 week loaded samples, when averaged across all
regions, averaged across all quadrants and when isolated to each individual region or
quadrant. Including p-values of .0565 or less, 5 week loaded samples showed statistically
higher densities of apoptotic osteocytes than 5 week unloaded control samples for each
quadrant, when averaged across all regions, and for each region, when averaged across all
quadrants and when looking at the cranial and caudal quadrants individually. For 2 week
loaded versus 5 week loaded samples, all 5 week loaded quadrants, except the cranial
quadrant, showed higher densities of apoptotic osteocytes, when averaged across all
regions. Also, densities of apoptotic osteocytes were higher in 5 week loaded midshafts,
when averaged across all quadrants and when analyzed in the caudal or lateral quadrants
individually. The percentage of viable osteocytes in 5 week loaded bones was
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significantly higher than in 2 week loaded bones for all quadrants, when averaged across
all regions, and in all regions, when averaged across all quadrants.
Fitting with this study's hypothesis, 5 week loaded samples showed the biggest
differences when compared with all other samples, especially in terms of the density and
percentage of apoptotic osteocytes present. Statistically significant values, indicating that
each quadrant and region in 5 week loaded samples had a higher percentage of apoptotic
osteocytes than any other sample group, provides strong evidence in support of increased
apoptosis and regional variations in samples that are cyclically loaded. 5 week loaded
samples also showed an increase in the density of apoptotic osteocytes, but not to the
same magnitude that the percent of apoptotic osteocytes data showed. There were also
many statistically significant regions and quadrants showing increased viable osteocytes
in 5 week loaded samples compared to 2 week loaded samples. This difference was not
also observed between 5 week loaded samples and the controls because the difference
appears to be due to the specific time points in which the two difference loading groups
were loaded and subsequently sacrificed. As previously discussed, the 2 week loaded
samples may have shown slightly more apoptotic osteocytes and less viable osteocytes
than 2 week unloaded samples because, as described by Noble, samples exhibited less
apoptotic and viable osteocytes as well as the first signs of remodeling at 14 days after
the initial damage stimulus from loading. In the same study by Noble et al., at 7 days
after loading, more osteocytes with DNA fragmentation and similar viable osteocytes,
when compared to the control samples, were seen (Noble, et al. 2003). These two
observations, from Noble's study, help shed light on why statistically significant
differences in the amount of viable osteocytes were only observed between 5 week and 2
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week loaded samples. All of these previously discussed trends involving the 5 week
loaded samples, showing increased values apoptotic and viable osteocyte values in these
samples, are further strengthened by the fact that no significant trends were observed
when comparing the 2 week unloaded samples against both the 2 week loaded and 5
week unloaded samples, thus agreeing with the rationalizations given in this discussion as
well as the observations presented here from other studies; only 5 week loaded samples,
in this study, showed multiple statistically significant differences to other samples.
The results from this study were focused on quantifying variations in the amount
of apoptotic osteocytes present in loaded mice hindlimbs, unloaded mice hindlimbs and
any differences there may be between the two, in an attempt to better explain the
mechanisms and factors in which bone remodeling is initiated. Bones repair and replace
themselves in response to the specific mechanical loads that they experience throughout
each region (Noble, et al. 2003). How bones specifically use this information has been a
question that has attempted to be answered by various theories, one of which involves
naming apoptotic osteocytes as the signaling mechanism in which osteoblasts and
osteoclasts are targeted, as necessary. The data from this study did in fact support the
hypothesis that osteocyte apoptosis was increased and regional variations were enhanced
due to cyclical loading applied to murine tibias. Other research has similarly made
observations about bone remodeling and osteocyte apoptosis. One study, by Noble et al.,
demonstrated a U-shaped correlation with osteocyte apoptosis and bone loading, with
disuse and fatigue loading microdamage showing increased apoptosis (Noble, et al.
2003). A study by Verborgt et al. showed that microdamage caused by fatigue loading
showed increased levels of apoptotic osteocytes, especially concentrated around the

86

regions with microdamage or resorption (Verborgt, et al. 2000). Another study, by
Cardoso et al., showed similar results indicating how apoptotic osteocytes are temporally
and spatially linked to fatigue induced microdamage and the intracortical bone
remodeling that follows (Cardoso, et al. 2009). A study by Hedgecock et al. showed a
strong correlation between apoptotic osteocytes and remodeling parameters (Hedgecock,
et al. 2007). In the same study, the researchers stated that their approximation of viable
osteocytes showed no linear correlation with any of the remodeling or modeling factors
studied (Hedgecock, et al. 2007). Although there is still much information lacking,
especially in terms of the specific cellular interactions and communication networks at
play from the beginning initiation of the remodeling process to the end of it, it is the hope
of this study that the data analyzed and discussed within joins the previously mentioned
studies in providing evidence in support of the role that apoptotic osteocytes must play in
the remodeling process.
4.1 Limitations
Despite being a continuation of a previous study (Chan 2011), there are many
limitations to the current study. Firstly, efforts were put forth to maintain all mice under
the same day to day conditions by giving them similar living, dietary and loading
conditions. However, as the mice were allowed to move around day to day, when not
being loaded, there may have been some differences in the amount of exercise that each
mouse received. Secondly, even though care was taken to ensure consistency from
sample to sample when taking cross-sectional slices from the distal, midshaft and
proximal regions of each sample, the location within each region that sample was taken
from may have been different from subject to subject, which may cause unwanted
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differences when analyzing the data. In regards to the TUNEL and methyl green staining,
best efforts were put forth to use the same staining procedure with all samples for
equivalency, however, some samples showed clearer color, indicating that the staining in
some samples may have been better than others; TUNEL staining may also be subject to
false staining which may have affected some of the counted data. In order to perform the
TUNEL and methyl green staining, two adjacent samples were cut and the TUNEL stain
was applied to one sample while the methyl green was applied to the other. Although this
eliminated some of the problems encountered with co-staining, the two adjacent samples
used may not have been entirely similar, which could have caused more unwanted
differences or discrepancies in the data analysis. Also, by not co-staining the two
methods together, the TUNEL stain may have incorrectly stained non-apoptotic
osteocytes that contain DNA breaks, which was not accounted for in this study
(Hedgecock, et al. 2007).When counting the amount of apoptotic and viable osteocytes
present in each sample, there may have been some error in the actual values counted as
this was done one by one by a single person, which leaves room for potential error.
4.2 Applications and Future Work
Experiments such as the current study provide more information surrounding
apoptotic osteocytes and their role in the bone remodeling process. The results from this
study give support to the idea that apoptotic osteocytes play an important role in bone
remodeling and give data showing differences between unloaded and loaded bones in
terms of apoptotic osteocytes. Future work should be performed to further look at the
effects that apoptotic osteocytes have on neighboring cells and communication networks.
This may include looking deeper into any signaling, an example being osteoclastogenic
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signaling, that may be occurring between other neighboring osteocytes, both apoptotic
and non-apoptotic, as well as any spatial or temporal patterns between the cells present
while various types of remodeling communication is occurring.
4.3 Conclusion
This study set out to demonstrate regional and quadrant differences, namely
increases in the number of apoptotic and viable osteocytes, in cyclically loaded murine
tibiae when compared with unloaded bones in attempt to provide evidence in support of
apoptotic osteocytes playing a role in the remodeling process. The results of this study
showed increased apoptotic osteocytes, both in percentage and density, for the 5 week
loaded samples when compared against the unloaded controls as well as the 2 week
loaded bones. An increased percentage of viable osteocytes was also observed in the 5
week loaded bones when compared with the 2 week loaded samples. Individually, 5 week
loaded samples also showed the most enhanced regional variation. Overall, 5 week
samples showed an increase in apoptotic osteocytes as well as the most regional and
quadrantal variation when compared against all other samples, thus, supporting our initial
hypothesis and providing evidence in support of apoptotic osteocytes playing a role in the
remodeling process. Further research that delves into the specific mechanisms of how
apoptotic osteocytes help initialize bone remodeling as well as other potential localized
interactions or communication that apoptotic osteocytes provide will further our
understanding of the human body and the bone remodeling process.
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APPENDICES
Appendix A
Mice Loading Protocol
Equipment needed:
Bose Enduratec 3220
Load cell
Wintest PCI control system
Enduratec signal box
Mouse fixture with weights
Surgical tape
Q-tips
Procedure:
1) Turn on the Enduratec signal box, Wintest PCI control system and the computer.
2) Open the program: WinTest
3) File Open Project  05-177 Cal poly pchang test.prj
4) Setup  Limits Display check limits (ensure that fixture will not hit bottom of the
plunger)
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5) Setup Channels Autotare

6) Feedback Set axial feedback to displacement
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7) LocalHigh (means displacement can be adjusted live)
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8) Click position button raise so that the mouse can fit underneath the plunger
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9) Ensure that nose cone is fasten securely with the chemistry stand and that it is not
touching the fixture. Chemistry stand should be secured to the table with C-clamps.
10) Set up the isoflurane anesthesia machine so that it is connected to the anesthesia
chamber but readily available to be connected to the nose cone tubing.
11) In the chamber, 4.5% isoflurane should be release at 3L/min.
12) Place a piece of surgical tape on the forelimbs of the mouse.
13) Once anesthetized in the chamber, the chamber tubing should be switched with the
nose cone tubing and the anesthesia machine should be set to 2% isoflurane at 1L/min.
14) The mouse is then placed on top of the ramp fixture.
15) Ensure that the nose of the mouse is secured in the nose cone (use the pieces of the
tape on the forelimbs to help secure the nose location).
16) Put left heel of the mouse into the groove on the ramp fixture. Use a piece of surgical
tape to secure the foot down.
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17) Lower the plunger position slowly until a force of -0.04 N is achieved. Use the q-tip
to push the top of the femur so that the knee joint is fully constrained by the plunger cup
indentation.
18) Click waveform block signal tab peak/valley browsename the file.
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19) Click the scope for group 1 eraser icon

20) Hit the disk icon save scope export file (turns yellow)

99

21) Click on run zero start

22) Once it finishes, click the disk icon again and name the file.
23) Click the position icon  raise the plunger until the mouse
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Appendix B
Microtome Protocol
1) Put paraffin embed sample block(s) in the refrigerator for at least 30 minutes.
2) Wash hands and water bath with soap (try not to get the front of the water bath wet).
3) Dry with paper towels.
4) Put gloves on.
5) Fill water bath with distilled water.
6) Write name in the logbook.
7) Use the lever to secure wax block in the holding mechanism.
8) Insert the blade into the designated slot and lightly tighten until secure.
9) Release the handle lock on the right side of the microtome.
10) Push the base, holding the blade, up to the tissue block and lock in place.
11) Set the microtome to 20 µm and face the block a few times to take off the top layers
of wax and reveal the bone.
12) Set the microtome to 7 µm and cut sections as needed.
13) Use the tweezers to carefully carry and place the sections in the water bath
14) Use blunt dissection cuts to separate individual sections so they fit on a microscope
slide.
15) Angle the microscope slide into the water below the sections and raise it slowly to the
surface ensuring that the section gets carefully placed onto the microscope (be sure that
the microscope slide is oriented properly so that it can still be written on and labeled).

101

Appendix C
TUNEL and Methyl Green Staining Procedures
TUNEL Staining Procedure
1. Deparaffinize the tissue sections
Immerse the slides in xylene for 5 minutes
2. Immerse in 100% ethanol for 8 minutes (wash)
3. Rehydrate through graded ethanol washes
95% ethanol for 3 minutes
85% ethanol for 3 minutes
70% ethanol for 3 minutes
50% ethanol for 3 minutes
4. Air dry for 20 minutes
5. Immerse in PBS for 5 minutes (wash)
6. Immerse in HistoChoice for 15 minutes (fix)
7. Immerse in PBS for 10 minutes (wash)
8. Remove liquid from tissue and place slides on a flat surface
Prepare a 20 µg/ml proteinase k solution:
1 part 10 mg/ml proteinase k stock solution (see Appendix for procedure)
to
499 parts PBS
Add 100 µL of the proteinase k solution to each slide to cover the tissue section
Incubate slides for 10 to 30 minutes (set out to dry)
Use shorter incubation times because of the thinner sections.
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9. Immerse in PBS for 5 minutes (wash)
10. Immerse in HistoChoice for 5 minutes (refix)
11. Immerse in PBS for 5 minutes (wash)
For positive control: treat sample with DNase I  causes DNA fragmentation
12. Tap the slides to remove excess liquid (use Kimwipes)
Cover the cells with 100 µL of equilibration buffer
Equilibrate for 5 to 10 minutes
13. Thaw biotinylated nucleotide mixture on ice
Prepare rTdT reaction mixture, keep on ice
100 µL of the reaction mixture per slide will be enough to cover the section
For positive control:
Combine:

98 µL of equilibration buffer
1 µL of biotinylated nucleotide mixture
1 µL of rTdT

14. Blot around equilibrated areas with tissue paper
Add 100 µL of the rTdT reaction mixture to the sections on each slide
Do not allow the sections to dry out
15. Cover the sections with plastic coverslips to evenly distribute the reagent
Incubate at 37 degrees C for 60 minutes inside of a humidified chamber (wet paper
towel over dish)
This step allows the end-labeling reaction to occur
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16. Dilute:

1 part 20x SSC solution
to
10 parts deionized water

Remove coverslips
Immerse in the 2x SSC solution for 15 minutes
This step terminates the end-labeling reaction
17. Immerse in fresh PBS for 15 minutes (wash)
This step removes unincorporated biotinylated nucleotides
18. Dilute:

1 part 3% hydrogen peroxide
to
10 parts PBS

Immerse in the 0.3% hydrogen peroxide solution for 3 to 5 minutes
Do not use the 20x hydrogen peroxide
This step blocks endogenous peroxidases
19. Immerse in PBS for 15 minutes (wash)
20. Dilute streptavidin HRP solution 1:500 in PBS
Add 100 µL to each slide
Incubate for 30 minutes (set out to air dry)
21. Immerse in PBS for 15 minutes (wash)
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22. Combine DAB components right before use
Add 50 µL of DAB substrate 20x buffer to 950 µL of deionized water
Add 50 µL of DAB chromagen and 50 µL of hydrogen peroxide 20x
Add 100 µL of this DAB mixture to each slide and develop until there is a light
brown background, approximately 20 minutes
Keep DAB components and mixture away from light and use mixture within 30 minutes
23. Rinse several times in deionized water
24. Mount slides with permount

Methyl Green Staining Procedure
1. Do steps 1 through 4 of TUNEL procedure
To do simultaneously with the TUNEL procedure, offset the Methyl Green slides by 8
minutes behind.
2. Immerse in deionized water for 5 minutes
3. Immerse in 2% Methyl Green for 45 seconds
4. Rinse in distilled water
5. Rinse in deionized water
6. Mount slides with permount
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Proteinase k Reconstitution Procedure
Proteinase k comes in a powdered form and needs to be reconstituted with a proteinase k
buffer solution.
Proteinase k Buffer:
100mM Tris-HCl (pH 8.0)
50mM EDTA
1. Micropipette 0.100 mL of 1M Tris-HCl (pH 8.0) into a 1 mL aliquot.
2. Micropipette 0.100 mL of 0.5M EDTA (pH 8.0) into the aliquot.
3. Bring the volume to 1 mL with deionized water.
4. Mix 10 mg of the proteinase k powder with 1 mL of the buffer.
This reconstituted proteinase k will be a 10mg/mL solution.
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